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Abstract 
The overall aim of this dissertation is to better understand the mechanisms determining 
skeletal muscle oxygen delivery-utilization matching in health and disease. Emphasis is directed 
toward the role of nitric oxide (NO) bioavailability in modulating muscle microvascular 
oxygenation (PO2mv; the sole driving force for blood-myocyte oxygen flux) during transitions in 
metabolic demand. The first investigation of this dissertation (Chapter 2) demonstrates that 
alterations in NO bioavailability have a major impact on skeletal muscle PO2mv kinetics 
following both the onset and cessation of contractions. Specifically, increased NO levels (via the 
NO donor sodium nitroprusside; SNP) elevates whereas reduced NO levels (non-specific NOS 
inhibition with N
G
-nitro-L-arginine methyl ester; L-NAME) diminishes muscle PO2mv at the 
onset and during recovery from contractions in the spinotrapezius muscle of healthy young rats. 
Consistent with these results, inhibition of the neuronal NO synthase isoform (S-methyl-L-
thiocitrulline; SMTC; Chapter 3) reveals alterations in NO-mediated regulation of skeletal 
muscle PO2mv with advanced age that likely contribute to exercise intolerance in this population. 
In Chapter 4 we observed that pronounced oxidative stress is implicated in these pathological 
responses seen in aged and diseased states. Transient elevations in the oxidant hydrogen peroxide 
to levels seen in the early stages of senescence and cardiovascular diseases promote detrimental 
effects on skeletal muscle contractile function (i.e., augmented oxygen cost of force production). 
Chapter 5 demonstrates that endurance exercise training improves skeletal muscle microvascular 
oxygenation (i.e., greater PO2mv and slower PO2mv kinetics) across the metabolic transient 
partly via enhanced NO-mediated function in healthy young individuals. These data carry 
important clinical implications given that exercise training may ameliorate NO-mediated 
function, muscle microvascular oxygenation deficits and consequently exercise intolerance in 
aged and diseased populations. In conclusion, alterations in NO bioavailability have a major 
impact on the dynamic balance between skeletal muscle oxygen delivery and utilization (i.e., 
PO2mv kinetics) in health and disease. While advanced age or the predations of disease impair 
considerably skeletal muscle microvascular oxygenation, exercise training-induced adaptations 
on the oxygen transport system constitute a non-pharmacological therapeutic intervention 
potentially capable of mitigating these microcirculatory deficits. 
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Chapter 1 - Introduction 
 
Oxygen is essential for energy metabolism of multicellular complex organisms (e.g., 
mammals; ref. 4). Atmospheric oxygen must be transported by means of convection and 
diffusion through a series of transfer steps within closely integrated systems (pulmonary, 
cardiovascular and muscle metabolic) to reach the mitochondria and support oxidative 
metabolism (30). Physical exercise represents the greatest physiological challenge to those 
systems. Considering the small intramuscular oxygen and high energy phosphates stores, 
sustained elevations in adenosine triphosphate turnover during skeletal muscle contractions 
require an exquisitely tight coupling between oxygen delivery and utilization. 
 The microcirculation within skeletal muscle constitutes the final step in the oxygen 
transport pathway from lungs to myocytes and provides the surface area for oxygen and substrate 
exchange. As described by Fick’s law, oxygen diffuses from the microvascular blood to the 
mitochondria at a rate ( 2OV
 ) determined by the oxygen partial pressure (PO2) gradient (i.e., the 
PO2 difference between the capillary (PO2mv) and intracellular space (PO2intracel)), which 
constitutes the sole driving force for oxygen flux into the myocyte: 
 
)( 2222 racelintPOmvPODOOV 
  
 
where DO2 is the muscle effective diffusing capacity. Because PO2intracel falls close to zero 
during muscle contractions (15), PO2mv approximates the pressure gradient driving 
transcapillary oxygen flux. The temporal profile of skeletal muscle PO2mv during transitions in 
metabolic demand is determined by the dynamic matching of oxygen delivery ( 2OQ
 ) and 2OV  
(i.e., 22 / OVOQ
  ratio) (3, 19). Accordingly, alterations in skeletal muscle PO2mv have a direct 
impact on oxidative metabolism and contractile performance (13, 27). Understanding muscle 
microcirculatory control is therefore crucial to resolve the mechanisms that determine the 
dynamic matching between 2OQ
  and 2OV  in health and the dysfunction in aged and diseased 
states. Furthermore, as exercise training has become established as a standard non-
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pharmacological treatment for many patient populations, it is important to gain insights into its 
role in muscle microvascular structure and function to assist in the design of therapeutic 
strategies for improving exercise capacity. 
 Nitric oxide (NO) is a ubiquitous signaling messenger synthesized primarily via the 
conversion of L-arginine to L-citrulline by the enzyme NO synthase (NOS). All three major 
NOS isoforms are expressed in mammalian skeletal muscle, namely neuronal NOS (nNOS), 
endothelial NOS (eNOS) and inducible NOS (iNOS) (26). NO and its derivatives modulate 
multiple processes within skeletal muscle including hemodynamic and metabolic control (26). 
Specifically, NO contributes to the increase in skeletal muscle 2OQ
  during contractions 
primarily via endothelium-dependent vasodilation (12) and to the inertia of oxidative metabolism 
(i.e., finite 2OV
  kinetics) via inhibition of mitochondrial respiration (17). Accordingly, several 
lines of evidence indicate that impairments in NO-mediated function in aged and/or diseased 
states are associated with reduced exercise capacity (21, 22), whereas enhanced NO-mediated 
function following exercise training underlies, at least in part, improved exercise capacity (9, 
18). In this context, we developed the investigation described in Chapter 2 to examine the impact 
of altered NO levels on the dynamic skeletal muscle 22 / OVOQ
  matching (i.e., PO2mv kinetics) 
following the onset and cessation of contractions in healthy young rats. These data provide 
mechanistic evidence that alterations in NO bioavailability play a key role in determining 
skeletal muscle microvascular oxygenation and thus the upstream pressure driving capillary-
myocyte oxygen flux during transitions in metabolic demand in healthy young individuals. 
Moreover, based on those data we investigated how advanced age might impair NO-mediated 
control of skeletal muscle microvascular and contractile function (Chapter 3). 
 Advancing age is associated with a variety of cardiovascular perturbations that disrupt 
contracting skeletal muscle vascular control. Impairments in the oxygen transport pathway with 
aging result in temporal mismatch between muscle 2OQ
  and 2OV  during transitions in metabolic 
demand (2, 11) and likely contribute to reduced exercise capacity in this population (21). These 
alterations in PO2mv kinetics are considered to emanate, at least in part, from age-related 
disruptions in myocyte redox state. Enhanced reactive oxygen and nitrogen species accumulation 
during muscle contractions (6, 16) coupled with impaired antioxidant mechanisms in old 
individuals (31) might exacerbate the underlying oxidative stress characteristic of aging (7) and 
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promote NOS uncoupling and/or direct NO inactivation (10, 23, 28). In view of the typical 
deterioration of endothelial function in the elderly (21, 31), age-related decrements in NO-
mediated function have been ascribed traditionally to eNOS dysfunction. In Chapter 3 we 
examined whether nNOS dysfunction is mechanistically involved in the 22 / OVOQ
  mismatch 
during metabolic transitions in aged skeletal muscle. Identifying the detrimental effects of aging 
on distinct NOS isoforms represents the initial step toward the development of potential 
therapeutic strategies targeting specific enzymes. 
 As mentioned above, alterations in redox state modulate significantly skeletal muscle 
vascular and metabolic control. It is interesting to note that aged and diseased states (e.g., 
chronic heart failure, hypertension, diabetes) are associated with prominent oxidative stress 
(characterized by reactive oxygen species accumulation that overwhelms the buffering capacity 
of the endogenous antioxidant system) and reduced exercise capacity. Oxidants are produced at 
multiple sites within the skeletal muscle and vasculature at rest and during contractions (6, 16, 
24). The reduction of molecular oxygen by one-, two- and three-electron transfer reactions yields 
the oxidizing agents superoxide anion (O2
•-
), hydrogen peroxide (H2O2) and hydroxyl radical 
(
•
OH). H2O2, a small diffusible and ubiquitous molecule with a long half-life relative to other 
reactive oxygen species, is regarded as one of the most influential oxidants in terms of redox 
signaling (8). Accordingly, acute alterations in H2O2 bioavailability have important implications 
for skeletal muscle function at rest and during metabolic transients, including the modulation of 
arteriolar tone (5), mitochondrial respiration (29) and force production (1, 25). In Chapter 4 we 
examined the impact of transient elevations in H2O2 to levels found in the early stages of 
senescence and cardiovascular diseases (e.g., hypertension) on resting and contracting skeletal 
muscle microvascular oxygenation (PO2mv kinetics) and force production in healthy young 
individuals. 
 Contrary to aged and diseased states, endurance exercise training induces multiple 
structural and functional adaptations that enhance the capacities for skeletal muscle 2OQ
  and 
2OV
  (14, 20). These adaptations rely partially on improvements in NO-mediated function that 
occur via upregulation of NOS expression and/or activity in conjunction with augmented 
antioxidant capacity (9, 18). In Chapter 5 we determined the effects of endurance exercise 
training on skeletal muscle PO2mv kinetics and the mechanistic role of NO to these potential 
adaptations in healthy young rats. These data set the stage for future investigations employing 
4 
 
exercise training protocols as a non-pharmacological tool to ameliorate muscle microvascular 
oxygenation deficits and exercise intolerance in aged and diseased populations. 
 Taken together, the investigations described herein were designed to further our 
understanding of the mechanisms determining skeletal muscle 22 / OVOQ
  matching in health and 
disease. Significant focus is given to the role of NO bioavailability in modulating muscle PO2mv 
kinetics during transitions in metabolic demand. Each chapter is self-contained following 
standard journal article format and a comprehensive conclusion is provided for this series of 
investigations (Chapter 6). 
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Chapter 2 - Nitric oxide bioavailability modulates the dynamics of 
microvascular oxygen exchange during recovery from contractions 
9 
 
 Summary 
 
Lowered microvascular PO2 (PO2mv) during the exercise off-transient likely impairs 
muscle metabolic recovery and limits the capacity to perform repetitive tasks. The current 
investigation explored the impact of altered nitric oxide (NO) bioavailability on PO2mv during 
recovery from contractions in healthy skeletal muscle. We hypothesized that increased NO 
bioavailability (sodium nitroprusside; SNP) would enhance PO2mv and speed its recovery 
kinetics while decreased NO bioavailability (L-nitro arginine methyl ester; L-NAME) would 
reduce PO2mv and slow its recovery kinetics. PO2mv was measured by phosphorescence 
quenching during transitions (rest - 1 Hz twitch-contractions for 3 min - recovery) in the 
spinotrapezius muscle of Sprague-Dawley rats under SNP (300 μM), Krebs-Henseleit (Control) 
and L-NAME (1.5 mM) superfusion conditions. Relative to recovery in Control, SNP resulted in 
greater overall microvascular oxygenation as assessed by the area under the PO2mv curve 
(PO2AREA; Control: 3471 ± 292 mmHg.s; SNP: 4307 ± 282 mmHg.s; P<0.05) and faster off-
kinetics as evidenced by the mean response time (MRToff; Control: 60.2 ± 6.9 s; SNP: 34.8 ± 5.7 
s; P<0.05), whereas L-NAME produced lower PO2AREA (2339 ± 444 mmHg.s; P<0.05) and 
slower MRToff (86.6 ± 14.5 s; P<0.05). In conclusion, NO bioavailability plays a key role in 
determining the matching of O2 delivery-to-O2 uptake and thus the upstream O2 pressure driving 
capillary-myocyte O2 flux (i.e., PO2mv) following cessation of contractions in healthy skeletal 
muscle. Additionally, these data support a mechanistic link between reduced NO bioavailability 
and prolonged muscle metabolic recovery commonly observed in aging and diseased 
populations. 
10 
 
 Introduction 
 
Daily life is rarely accompanied by constant energetic demands (i.e., steady-state oxygen 
utilization ( 2oV
 )) and consequently prolonged muscle metabolic recovery will impair the ability 
to perform repetitive activities. Reduced O2 availability following the cessation of submaximal 
contractions will decrease the O2 pressure within the microvasculature (PO2mv) and, in so doing, 
slows the rate of skeletal muscle metabolic recovery (28, 33). As described by Fick’s law, O2 
diffuses from the microvascular blood to the mitochondria at a rate ( 2oV
 ) determined by the 
oxygen pressure (PO2) gradient (i.e., the PO2 difference between PO2mv and the intracellular 
space (PO2intra)), which constitutes the sole driving force for O2 flux into the myocyte: 
 
)( 2222 intraPomvPomDooV 
  
 
where DO2m is the muscle effective diffusing capacity. Because PO2intra falls close to zero 
during contractions (32), PO2mv approximates the PO2 gradient driving transcapillary O2 flux. 
The temporal profile of skeletal muscle PO2mv during transitions in metabolic demand is 
determined by the dynamic matching of oxygen delivery ( 2oQ
 ) and 2oV  (i.e., 2oQ
 / 2oV  ratio) (5, 
48). In this context, evaluation of PO2mv off-kinetics is of crucial importance since a lowered 
2oQ
 / 2oV  ratio will, via decreased PO2mv and blood-myocyte O2 flux, retard the rate of oxidative 
phosphorylation during recovery thereby impairing subsequent contractile performance (42). 
Conditions associated with reduced nitric oxide (NO) bioavailability and/or 
downregulation of endothelial function such as aging (51, 64) and chronic heart failure (CHF; 
17, 19) are characterized by decreased exercise tolerance (11, 34). Therefore, it is conceivable 
that reduced NO bioavailability is linked mechanistically to compromised muscle function 
through impaired 2oQ
 / 2oV  matching and lowered PO2mv. NO and its derivatives mediate 
multiple biological responses, including the modulation of vascular smooth muscle tone and 
skeletal muscle oxidative metabolism (rev. 9, 71). Specifically, considerable evidence indicates 
that NO contributes to the sustained vasodilation (and thus 2oQ
 ) during recovery from 
contractions (25, 59, 67). Moreover, NO synthase (NOS) inhibition (i) accelerates 2oV
  kinetics 
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at the onset of contractions in humans (35, 36, 73) and horses (38, 39) but not in the isolated 
canine muscle preparation (26); and (ii) increases skeletal muscle 2oV
  at rest and during 
submaximal exercise in dogs (65). 
The purpose of the present investigation was to determine the effects of altered NO 
bioavailability on PO2mv kinetics during recovery from contractions in healthy rat skeletal 
muscle. Considering that NO bioavailability modulates 2oQ
 / 2oV  matching following the onset 
of contractions in health (23) and is implicated in the 2oQ
 / 2oV  dysregulation characteristic of 
aging and diseased populations (20), the following hypotheses were tested: (i) increased NO 
bioavailability (via the NO donor sodium nitroprusside; SNP) would elevate PO2mv throughout 
recovery from contractions and accelerate PO2mv off-kinetics; while (ii) reduced NO 
bioavailability (NOS blockade via L-nitro arginine methyl ester; L-NAME) would lower PO2mv 
throughout recovery from contractions and slow PO2mv off-kinetics relative to the control 
condition. 
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 Methods 
 
Animals 
 Seven female Sprague-Dawley rats (body mass = 298 ± 10 g) were used in the present 
study. The on-transient PO2mv response from these animals has been the focus of a previous 
study (23). Results from the present investigation focus on the off-transient PO2mv response. 
Due to animal preparation instability (e.g., movement of the PO2mv measurement plane during 
electrically-induced muscle contractions), off-transient PO2mv profile analysis could not be 
obtained from one rat in the Control, two rats in the SNP, and three rats in the L-NAME groups. 
Therefore, results from the current investigation are presented from animals under the following 
conditions, Control: n = 6; SNP: n = 5; L-NAME: n = 4. Animals were maintained on a 12:12 
hour light-dark cycle and received water and food ad libitum. Upon completion of the study, rats 
were euthanized with an overdose of pentobarbital sodium (>100 mg.kg
-1
, i.a.). All protocols 
described herein were approved by the Kansas State University Institutional Animal Care and 
Use Committee (IACUC). 
 
Surgical preparation and experimental protocol 
 All rats were anesthetized initially with pentobarbital sodium (~35-50 mg.kg
-1
, i.p.) 
administered to effect and maintained at a constant core temperature at ~37-38°C with a heating 
pad. The level of anesthesia was monitored frequently throughout the experimental protocol via 
the toe-pinch reflex and supplemented as necessary. The left carotid artery was surgically 
isolated and cannulated (PE-50; Intra-Medic Tubing, Clay Adams Brand, Sparks, MD, USA) for 
continuous monitoring of mean arterial blood pressure (MAP; Digi-Med BPA model 200, 
Louisville, KY, USA), infusion of the phosphorescent probe palladium meso-tetra (4-
carboxyphenyl) porphyrin dendrimer (R2; 15 mg.kg
-1
 i.a.) and blood sampling. Blood was 
sampled at the end of each experimental protocol for the determination of arterial blood gases 
and pH (Nova Stat Profile M, Waltham, MA, USA). 
 The surgical preparation consisted of opening the skin and fascia from the mid-dorsal 
region of the rat to expose the right spinotrapezius muscle. The spinotrapezius muscle exhibits a 
mixed fiber type composition and citrate synthase activity that resembles the human quadriceps 
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(16, 45), thus representing a useful analog of human locomotor muscle. The spinotrapezius 
muscle was moistened constantly throughout the surgical preparation via superfusion of Krebs-
Henseleit (K-H) bicarbonate-buffered solution (4.7 mM KCl, 2.0 mM CaCl2, 2.4 mM MgSO4,  
131 mM NaCl and 22 mM NaHCO3) equilibrated with 5% CO2–95% N2 at ~38°C. Stainless 
steel electrodes were sutured to the rostral (cathode) and caudal (anode) regions of the 
spinotrapezius muscle using 6-0 sutures to ensure unchanged electrode position throughout the 
procedures. 
 Three separate contraction bouts were performed under distinct superfusion conditions. 
The order of superfusion was SNP (300 μM in K-H), K-H (Control) and L-NAME (1.5 mM in 
K-H). These concentrations were selected based on preliminary studies in our laboratory (23). L-
NAME was in all instances the last treatment because of its relatively long half-life. The muscle 
was superfused with each solution (average flow rate of 1-2 mL.min
-1
, warmed to ~38°C) for a 
total time of 15-20 min prior to electrically-induced muscle contractions. Electrical stimulation 
(1 Hz, 4-6 V, 2 ms pulse duration) of the muscle was evoked via a Grass Stimulator (model S48, 
Quincy, MA, USA) for 3 min. The muscle was then allowed to recover for 3 min before the start 
of a ~10 min period of constant flushing to wash out the respective solution. Subsequent to the 
recovery and wash out periods the next condition was initiated (stimulation parameters held 
constant).  
 The spinotrapezius preparation exhibits reproducible PO2mv parameters during 
transitions in metabolic demand when a minimum of 20 min of recovery is allowed between 
contraction bouts (14, 29). Importantly, 25-30 min of recovery (10 min wash out and 15-20 min 
of condition-specific superfusion) was undertaken herein to avoid any priming (6) and drug 
ordering (23) effects that might confound the experimental interpretation of the PO2mv responses 
to muscle contractions.  
 
Measurement of PO2mv 
 PO2mv was measured by phosphorescence quenching using a Frequency Domain 
Phosphorometer (PMOD 1000, Oxygen Enterprises, Philadelphia, PA, USA). As described 
previously (5, 48), the phosphorescence quenching technique applies the Stern-Volmer 
relationship (63) for determination of PO2mv based on the time constant of phosphorescence 
decay at the muscle: 
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)/(]1)/[(2   QkmvPo  
 
where Qk  is the quenching constant and   is the phosphorescence lifetime in an O2-free 
environment. The   of phosphorescence decay was determined using 10 scans (100 ms) in the 
single frequency mode (63, 72). The phosphor R2 (   = 601 μs and Qk  = 409 mmHg
.s
-1
 at pH = 
7.4 and temperature ~38°C) was infused ~15 min prior to initiation of spinotrapezius 
contractions. The R2 probe is bound to albumin and is restricted to the intravascular space within 
the muscle (57), providing a signal that corresponds to the weighted average of muscle 
microvascular volume sampled (i.e., mostly capillaries; 58). Therefore, PO2mv describes the O2 
pressure head for diffusive blood-myocyte O2 transfer. The common end of the bifurcated light 
guide was placed 2-4 mm superficial to the dorsal surface of the exposed muscle. The 
phosphorometer modulates sinusoidal excitation frequencies between 100 Hz and 20 kHz, which 
allows phosphorescence lifetime measurements from 10 μs to ~2.5 ms. The excitation light (524 
nm) focuses on a circle of ~2 mm diameter of exposed muscle with a resulting penetration depth 
of ~500 μm. PO2mv measurements were recorded at 2 s intervals during rest and throughout the 
duration of the contraction (3 min) and recovery (3 min) periods. 
 
Analysis of PO2mv kinetics 
 The kinetics of PO2mv were described by nonlinear regression analysis using the 
Marquardt-Levenberg algorithm (SigmaPlot 9.01; Systat Software, San Jose, CA, USA) for the 
recovery period. Transient PO2mv responses were fit with either a one- or two-component model 
(48): 
 
One-component: 
)1( /)(2con)(end2)(2
TDt
t emvPomvPomvPo

   
 
Two-component: 
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/)(
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/)(
21con)(end2)(2
 TDtTDt
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
   
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where PO2mv(t) is the mvPo2  at a given time t, PO2mv (end-con) is the end-contraction PO2mv, Δ1 
and Δ2 are the amplitudes for the first and second components, respectively, TD1 and TD2 are the 
independent time delays for each component, and τ1 and τ2 are the time constants (i.e., time taken 
to reach 63% of the response) for each component. Goodness of fit was determined using three 
criteria: (i) the coefficient of determination (r
2
); (ii) the sum of the squared residuals ( 2 ); and 
(iii) visual inspection. 
The mean response time for the off-transient (MRToff; as calculated by 47) was used to 
describe the overall dynamics of the PO2mv response: 
 
One-component: 
TDMRT  
 
Two-component: 
))(/())(/( 222111   TDTDMRT tottot  
 
where Δ1 and Δ2, TD1 and TD2, and τ1 and τ2 are defined above and Δtot corresponds to the total 
change in PO2mv (i.e., Δ1 + Δ2) when using the two-component model. Furthermore, the overall 
time necessary to reach 63% of the final amplitude of the response during recovery was 
determined independent of modeling procedures (T63; 38) as an additional means of checking the 
model fits to the data. 
The area under the PO2mv curve plotted as function of time (PO2AREA) was calculated 
during 3 min following cessation of contractions to provide an index of overall muscle 
microvascular oxygenation throughout the exercise transient for each condition (i.e., 
incorporating end-contraction and end-recovery PO2mv values, amplitudes, time delays and time 
constants of the response to yield a value expressed in mmHg.s). 
 
Statistical analysis 
The MRT, T63, pre-contracting PO2mv (PO2mv(Baseline)) and PO2mv(end-rec) were compared 
among (Control vs. SNP vs. L-NAME) and within (MRTon vs. MRToff; MRToff vs. T63; 
PO2mv(Baseline) vs. PO2mv(end-rec)) groups with two-way ANOVAs. All other comparisons among 
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groups were conducted with one-way ANOVAs. Post hoc analyses were performed with the 
Student-Newman-Keuls test when a significant F-ratio was detected. The level of significance 
was set at P<0.05. Unidirectional probabilities were considered when examining the effects of 
SNP and L-NAME superfusion on PO2mv kinetics based on initial directional hypotheses (20, 
23). Pearson’s product-moment correlations were conducted to determine association between 
variables using individual animal data. Results are reported as mean ± standard error of the mean 
(SE). 
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 Results 
 
Arterial PO2 was 99 ± 3 mmHg, O2 saturation 93 ± 1 % and blood pH 7.45 ± 0.01. SNP 
superfusion promoted a systemic vasodilation which decreased MAP when compared to Control 
and L-NAME conditions (SNP: 99 ± 5; Control: 126 ± 3; L-NAME: 126 ± 4 mmHg; P<0.05). 
 
Effects of altered NO bioavailability on PO2mv kinetics during the off-transient 
 The time course of PO2mv following the cessation of contractions during SNP and L-
NAME treatments presented significant qualitative and quantitative differences relative to the 
Control condition (Fig. 2.1 and Table 2.1). Specifically, PO2mv(end-con) was higher for SNP and 
lower for L-NAME when compared to Control (P<0.05). The one-component exponential model 
provided an excellent fit to the PO2mv data for Control and SNP. Conversely, a more complex 
two-component exponential model was required to fit the L-NAME response. Within the three 
different experimental conditions (Control, SNP and L-NAME), MRT (model dependent) and 
T63 (model independent) were not different from one another during the recovery protocol 
(P>0.05). 
In accordance with our hypotheses, SNP treatment accelerated PO2mv off-kinetics 
(MRToff, T63; P<0.05) while L-NAME slowed the response (MRToff, T63; P<0.05). It is 
noteworthy that the PO2mv(end-rec) reached during the recovery protocol was not different from 
the corresponding pre-contracting PO2mv value under each condition (PO2mv(Baseline); Control: 
24.0 ± 1.0; SNP: 25.9 ± 1.4; L-NAME: 16.9 ± 1.8 mmHg; P>0.05). The effects of altered NO 
bioavailability on PO2mv off-kinetics were reflected in the overall muscle microvascular 
oxygenation (PO2AREA) throughout the recovery period, as SNP was associated with greater 
PO2AREA whereas L-NAME induced smaller PO2AREA when compared to Control (Fig. 2.2). As 
illustrated in Fig. 2.3, PO2mv(end-con) was inversely correlated with MRToff across conditions (r = 
-0.64; P<0.01). 
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 Discussion 
 
The principal original finding of this investigation is that NO bioavailability exerts a key 
role on the mechanisms determining the dynamic matching between 2oQ
  and 2oV  following the 
cessation of contractions in healthy skeletal muscle. Consistent with our hypothesis, increased 
NO bioavailability (SNP) elevated PO2mv during the recovery phase and speeded its kinetics. 
Conversely, reduced NO bioavailability (L-NAME) decreased PO2mv during the recovery phase 
and slowed its kinetics. The effects of altered NO bioavailability on PO2mv off-kinetics can be 
summarized by analysis of the overall muscle microvascular oxygenation (PO2AREA), which was 
increased with SNP and decreased with L-NAME compared to Control. 
 
Effects of altered NO bioavailability on PO2mv off-kinetics 
Altering NO bioavailability in recovery is expected to impact (i) muscle 2oQ
  through 
modulation of smooth muscle relaxation and thus vascular conductance (71) and (ii) muscle 2oV
  
via regulation of oxidative metabolism (e.g., inhibition of cellular respiration by NO and its 
derivatives; 9). Considering that PO2mv represents the conflation of muscle 2oQ
  and 2oV  at any 
given time (5, 48), relative to Control increased NO bioavailability (SNP) should act to increase 
2oQ
  and decrease 2oV  while reduced NO bioavailability (L-NAME) is expected to decrease 
2oQ
  and increase 2oV  throughout recovery from contractions, thereby impacting PO2mv off-
kinetics. Since PO2mv denotes the sole driving force for blood-myocyte O2 flux, alterations in its 
off-kinetics influence the rate of oxidative phosphorylation during recovery and consequently the 
capacity to perform repetitive tasks (42). 
 SNP increased whereas L-NAME decreased PO2mv(end-con) relative to Control (Table 2.1 
and Fig. 2.1). Despite substantial within-group variability, we found a negative correlation 
between PO2mv(end-con) and MRToff across conditions (Fig. 2.3), suggesting that NO-mediated 
events that compromise microvascular oxygenation during steady-state contractions result in 
sluggish PO2mv recovery, at least in these young healthy muscles. Similar to the Control 
condition, SNP and L-NAME evidenced an initial time delay before any PO2mv increase during 
recovery which must result from a similar rate of change (or lack thereof) in 2oQ
  and 2oV  
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during the initial period following cessation of muscle contractions. The fact that PO2mv in 
recovery does not fall below PO2mv(end-con) denotes that 2oQ
 / 2oV  ratio and thus the driving force 
for capillary-myocyte O2 diffusion does not decrease further even under the L-NAME condition. 
It is noteworthy that the PO2mv profile in recovery during L-NAME was qualitatively similar 
(i.e., markedly slower than healthy control) to that found in conditions associated with reduced 
NO bioavailability such as aging (30) and CHF (3, 49). 
Our results are consistent with previous theoretical studies (3, 24, 30) indicating that the 
altered magnitude and kinetics of 2oQ
  and 2oV  impact the PO2mv profile during exercise 
transitions. Specifically, (i) a relatively lower end-contraction 2oQ
  amplitude and faster 2oQ
  off-
kinetics and/or (ii) a relatively higher end-contraction 2oV
  amplitude and slower 2oV  off-kinetics 
act to reduce PO2mv and slow its kinetics during recovery (i.e., 2oQ
 / 2oV  mismatch), 
consequently impairing muscle microvascular oxygenation. Taken together, these observations 
are consonant with decreased muscle 2oQ
  during exercise transitions in aging (1, 15, 27) and 
CHF (61) that result, at least in part, from blunted vasodilation secondary to decrements in 
endothelial function (17, 19, 51, 64). 
 
Effects of altered NO bioavailability on PO2mv on-off asymmetry 
 Comparison between the overall PO2mv kinetic profiles (assessed via MRT) during 
exercise on- and off-transients in healthy skeletal muscle has revealed an asymmetry (i.e., faster 
on- and slower off-kinetics; 50). These findings are consistent with reports of symmetrical on-off 
muscle 2oV
  (3, 43, cf. 62) combined with asymmetric 2oQ
  (fast on- and relatively slower off-
kinetics; 22, 40) profiles. In healthy muscle, faster on- and slower off-kinetics of capillary red 
blood cell flux (fRBC, an index of convective 2oQ
 ) relative to muscle 2oV  kinetics act to elevate 
mvPo2  and thereby O2 availability in skeletal muscle across exercise transitions (22, 40). 
Conceptually, the on-off asymmetry in the microvascular 2oQ
  profile suggests the participation 
of different mechanisms in the control of the blood flow response during the onset and recovery 
from contractions. Although the precise mechanisms underlying the time course of muscle blood 
flow throughout exercise transitions have not yet been elucidated (e.g., 12), asymmetric capillary 
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hemodynamics may result from the contribution of the muscle pump to exercise hyperemia 
during the onset but not offset of contractions in the healthy rat spinotrapezius muscle (22). 
On the other hand, conditions that impair muscle microvascular control such as CHF 
(61), aging (1, 15, 27) and diabetes (41, 54) are characterized by a lower 2oQ
 / 2oV  ratio during 
metabolic transients induced by muscle contractions (2, 4, 18, 55) and a greater degree of PO2mv 
on-off asymmetry (30, 49). Notwithstanding appreciable within-group variability, the negative 
correlation found between MRTon and MRToff (r = -0.64; P<0.02; Fig. 2.4) under Control, SNP 
and L-NAME treatments suggests a significant influence of altered NO bioavailability on PO2mv 
kinetics during both on- and off-transitions. This finding is in agreement with the role of NO (i) 
as an important component of the hyperemic response following the onset (31, 53, 65, 66) and 
cessation (25, 59, 67) of contractions; and (ii) as a modulator of the rate of oxidative 
phosphorylation at rest and during exercise transitions (9, 65). Where disease or advanced aging 
mandate an O2 supply dependency of 2oV
  kinetics (56), diminished NO bioavailability and/or 
downregulation of endothelial function will ultimately limit capillary-myocyte O2 flux thereby 
compromising pulmonary 2oV
  (10, 60, 68) during transitions in metabolic demand. 
 Considering the heterogeneous control of blood flow to skeletal muscle composed of 
distinct fiber types (rev. 44), slow-twitch fibers place a relatively greater reliance on increased 
convective 2oQ
  (and thus endothelium-dependent vasodilation; 31) while fast-twitch fibers 
mandate a greater O2 extraction in response to a given metabolic demand (7, 21, 50). In this 
context, the present results support that the progressively greater degree of PO2mv on-off 
asymmetry with increasing severity of CHF observed in slow- but not in fast-twitch fibers (49) 
can be attributed, at least in part, to reduced NO-induced vasodilation in CHF (17, 19). Similarly, 
aging induces muscle-specific dysfunction of endothelium-dependent vasodilation (primarily 
through diminished NO bioavailability; 51, 70) that is likely to increase the degree of PO2mv on-
off asymmetry only in slow-twitch fibers. 
The effects of altered NO bioavailability on microvascular oxygenation of the healthy 
spinotrapezius muscle during exercise transitions were such that the degree of PO2mv on-off 
asymmetry was abolished with SNP (i.e., MRTon and MRToff not significantly different) and 
markedly increased with L-NAME (faster MRTon and slower MRToff) relative to Control (Fig. 
2.5). Collectively, these findings provide a mechanistic basis for the greater degree of PO2mv on-
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off asymmetry (faster on- and slower off-kinetics) observed in conditions accompanied by 
reduced NO bioavailability and/or impaired endothelium-dependent vasodilation, for instance 
aging (30) and CHF (49). This behavior is likely involved in the reduced exercise tolerance 
during muscle contractions along with extended metabolic recovery that impairs the ability to 
perform repetitive tasks. 
 
Clinical implications 
 As noted above, limited O2 transport at the capillary-myocyte level is implicated in 
sluggish pulmonary 2oV
  kinetics (10, 68) and muscle metabolic (13, 37) recovery responses that 
may constrain the ability to perform repetitive daily activities (42) in aging and diseased (e.g., 
CHF) populations. Recently, Ferreira et al. (20) demonstrated that L-NAME superfusion had 
virtually no effects on PO2mv kinetics of rats with severe CHF, while SNP practically restored 
their PO2mv profile towards that seen in healthy animals during the onset of contractions. In 
addition, preliminary results from our laboratory suggest that the PO2mv time course during 
contractions in aged muscle responds in a similar fashion to that described previously in severe 
CHF under SNP and L-NAME treatments (SW Copp, KF Herspring, TI Musch, DC Poole; 
unpublished observations). Combined with the present results, these findings suggest that 
therapeutic interventions aimed at improving endothelial function (i.e., enhanced NO 
bioavailability) such as endurance exercise training (46, 70) or possibly augmented 
tetrahydrobiopterin levels (BH4; 69) could potentially ameliorate muscle microvascular 
oxygenation deficits (thereby reducing the pronounced degree of PO2mv on-off asymmetry) and 
increase exercise tolerance in the elderly and patients with CHF. 
 
Experimental considerations 
A lower perfusion pressure (MAP) for SNP compared to Control and L-NAME 
conditions could potentially constrain blood flow dynamics and thus influence PO2mv kinetics 
during exercise transients. However, recent evidence in healthy animals demonstrates that this 
effect is negligible when MAP is above ~70 mmHg (8) as herein. On the other hand, local L-
NAME superfusion of the spinotrapezius muscle prevented the potential confound of the marked 
MAP elevation that is usually seen following systemic NOS blockade which, if present, could 
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have triggered a partial baroreflex-mediated sympathetic withdrawal to compensate for the 
removal of NO vasodilation (66, cf. 59). 
Given the potential of altered NO bioavailability to impact intracellular redox state (52) 
and contractile function, it is important to consider that SNP and L-NAME treatments could 
influence the regulation of muscle microvascular oxygenation and muscle performance through 
mechanisms that do not directly involve NO. 
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 Conclusions 
 
In skeletal muscle, altered NO bioavailability impacts profoundly the dynamic matching 
between 2oQ
  and 2oV  during recovery from contractions. Increased NO bioavailability (SNP) 
enhanced muscle microvascular oxygenation (elevated PO2mv throughout recovery and faster 
off-kinetics) while reduced NO bioavailability (L-NAME) impaired muscle microvascular 
oxygenation (decreased PO2mv throughout recovery and slower off-kinetics) relative to Control. 
The importance of a lowered PO2mv is that it reduces the blood-myocyte O2 flux and could 
potentially constrain oxidative phosphorylation during transitions in metabolic demand. Such 
behavior may contribute to the reduced exercise tolerance found in aged individuals and CHF 
patients in whom NO bioavailability may be compromised (17, 19, 51, 64). Enhanced 
endothelial function (through increased NO bioavailability) produced by endurance exercise 
training in these populations (46, 69, 70) could serve to elevate PO2mv and thus benefit muscle 
metabolic control and increase exercise tolerance. The present investigation also supports that 
reduced NO bioavailability is implicated in the greater degree of  PO2mv on-off asymmetry 
(faster on- and slower off-kinetics) that is commonly observed in aging (30) and CHF (49). 
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Table 2.1 Muscle PO2mv kinetics during recovery from contractions under Control, SNP 
and L-NAME 
 Control SNP L-NAME 
PO2mv(end-con), mmHg 14.4 ± 1.3 18.3 ± 1.5* 8.2 ± 1.7*† 
Δ1PO2mv, mmHg 7.7 ± 1.2 7.3 ± 1.2 5.6 ± 1.2 
Δ2PO2mv, mmHg - - 5.7 ± 0.5 
PO2mv(end-rec), mmHg 22.1 ± 1.8 25.6 ± 1.8 16.6 ± 2.8*† 
TD1, s 3.3 ± 1.3 5.4 ± 2.3 3.6 ± 1.4 
TD2, s - - 81.5 ± 1.9 
τ1, s 56.9 ± 6.5 29.4 ± 5.3 52.4 ± 14.9 
τ2, s - - 64.9 ± 21.2 
MRToff, s 60.2 ± 6.9 34.8 ± 5.7* 88.6 ± 14.5*† 
T63, s 59.8 ± 7.2 36.0 ± 5.5* 98.0 ± 17.2*† 
PO2mv(end-con), end-contraction PO2mv; Δ1PO2mv, amplitude of the first component; Δ2PO2mv, 
amplitude of the second component; PO2mv(end-rec), end-recovery PO2mv; TD1, time delay for the 
first component; TD2, time delay for the second component; τ1, time constant for the first 
component; τ2, time constant for the second component; MRToff, mean response time for the 
off-transient; T63, time to reach 63% of the overall amplitude as determined independent of 
modeling procedures. * Significantly different from Control. † Significantly different from SNP. 
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Figure 2.1 Muscle PO2mv profiles during recovery from contractions under Control, SNP 
and L-NAME 
 
 
Figure 2.1 Mean muscle microvascular PO2 (PO2mv) during recovery from contractions under 
Control, sodium nitroprusside (SNP; increased nitric oxide) and L-nitro arginine methyl ester (L-
NAME; decreased nitric oxide) superfusion. Top and bottom panels exhibit absolute and relative 
PO2mv, respectively. SE bars omitted from bottom panel for clarity. Time zero depicts the onset 
of the recovery phase. Note that altered nitric oxide bioavailability markedly affected PO2mv 
kinetics during the off-transition in the healthy rat spinotrapezius muscle. 
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Figure 2.2 Overall muscle microvascular oxygenation during recovery from contractions 
under Control, SNP and L-NAME 
 
 
Figure 2.2 Mean values for the area under the muscle microvascular PO2 curve (PO2AREA) during 
recovery from contractions under Control, sodium nitroprusside (SNP) and L-nitro arginine 
methyl ester (L-NAME) superfusion. PO2AREA was obtained through integration of the area under 
the PO2mv curve over the 3 min of recovery from contractions for each condition. * Significantly 
different from Control. † Significantly different from SNP. 
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Figure 2.3 Correlation between PO2mv(end-con) and MRToff for each animal 
 
 
Figure 2.3 Correlation between PO2mv(end-con) and MRToff for each animal. Control (n = 6); 
sodium nitroprusside (SNP; n = 5); L-nitro arginine methyl ester (L-NAME; n = 4). PO2mv(end-
con), end-contraction PO2mv; MRToff, mean response time for the off-transient. Individual (filled 
symbols) and mean (open symbols) values are shown. 
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Figure 2.4 Correlation between MRTon and MRToff for each animal 
 
 
Figure 2.4 Correlation between MRTon and MRToff for each animal. On-transient data from 
Ferreira et al. (23). Control (n = 6); sodium nitroprusside (SNP; n = 5); L-nitro arginine methyl 
ester (L-NAME; n = 4). MRTon, mean response time for the on-transient; MRToff, mean 
response time for the off-transient. Individual (filled symbols) and mean (open symbols) values 
are shown. 
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Figure 2.5 Effects of altered nitric oxide bioavailability on muscle PO2mv on-off kinetics 
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Figure 2.5 Effects of altered nitric oxide bioavailability on the muscle microvascular PO2 
(PO2mv) on-off responses. Panels (a-c) depict the normalized change in mean PO2mv kinetics 
following the onset and cessation of contractions under sodium nitroprusside (SNP), Control and 
L-nitro arginine methyl ester (L-NAME) treatments, respectively. Filled symbols in panels (a-c) 
illustrate the ‘mirror image’ of data from Ferreira et al. (23) for PO2mv on-kinetics. SE bars 
omitted for clarity. Panel (d) shows the mean response time for the exercise on- (MRTon) and 
off- (MRToff) transients under Control, SNP and L-NAME. Note the symmetry between PO2mv 
on-off responses for SNP and the pronounced asymmetry for Control and L-NAME. * 
Significantly different from Control. † Significantly different from SNP. ‡ Significantly different 
from the on-transient within condition. See text for further details. 
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Chapter 3 - Effects of neuronal nitric oxide synthase inhibition on 
microvascular and contractile function in skeletal muscle of aged 
rats 
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 Summary 
 
Advanced age is associated with derangements in skeletal muscle microvascular function 
during the transition from rest to contractions. We tested the hypothesis that, contrary to what 
was reported previously in young rats, selective neuronal nitric oxide synthase (nNOS)-inhibition 
would result in attenuated or absent alterations in skeletal muscle microvascular oxygenation 
(PO2mv; which reflects the matching between muscle O2 delivery and utilization) following the 
onset of contractions in old rats. Spinotrapezius muscle blood flow (radiolabeled microspheres), 
PO2mv (phosphorescence quenching), O2 utilization ( 2OV
 ; Fick calculation) and submaximal 
force production were measured at rest and following the onset of contractions in anesthetized 
old male Fisher 344 x Brown Norway rats (27-28 mo) pre- and post-selective nNOS inhibition 
(2.1 µmol/kg S-methyl-L-thiocitrulline; SMTC). At rest, SMTC had no effects on muscle blood 
flow (p>0.05) but reduced 2OV
  by ~23% (p<0.05), which elevated basal PO2mv by ~18% 
(p<0.05). During contractions, steady-state muscle blood flow, 2OV
 , PO2mv and force 
production were not altered after SMTC (p>0.05 for all). The overall PO2mv dynamics at 
contractions onset was also unaffected by SMTC (mean response time; pre: 19.7 ± 1.5; post: 20.0 
± 2.0 s; p>0.05). These results indicate that the locus of nNOS-derived NO control in skeletal 
muscle depends on age and metabolic rate (i.e., rest vs. contractions). Alterations in nNOS-
mediated regulation of contracting skeletal muscle microvascular function with aging may 
contribute to poor exercise capacity in this population. 
40 
 
 Introduction 
 
Nitric oxide (NO) is a ubiquitous signaling messenger synthesized primarily through the 
conversion of L-arginine to L-citrulline by the enzyme nitric oxide synthase (NOS). Within 
skeletal muscle, NO plays a critical role in the modulation of several physiological processes 
including vascular relaxation, oxidative metabolism and excitation-contraction coupling (56). All 
three major NOS isoforms are expressed in mammalian skeletal muscle, namely neuronal NOS 
(nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) (56). Several lines of evidence 
indicate that NO derived from nNOS participates significantly in the matching of muscle O2 
delivery and utilization ( 22 / OVOQ
 ) at rest and during contractions as well as submaximal force 
production in healthy young individuals (12, see also refs. 13, 15, 19, 28, 33, 36, 39, 45, 52, 53, 
60). 
 Advancing age is associated with impairments in the O2 transport pathway and exercise 
capacity (47). Derangements in NO-mediated function likely represent one of the main 
mechanisms underlying temporal 22 / OVOQ
  mismatch during transitions in metabolic demand in 
aged skeletal muscle (5, 16, 23, 25). Impairments in the ability to regulate 2OQ
  relative to 2OV  
diminish muscle microvascular O2 pressures (PO2mv) and thus the driving force for blood-
myocyte O2 flux as dictated by Fick’s law of diffusion. These alterations are of functional 
significance given that reductions in PO2mv impact negatively on mitochondrial control and 
could explain, at least in part, poor exercise capacity with aging (29, 57). In view of the typical 
deterioration of endothelial function in the elderly (54, 65), age-related decrements in NO 
bioavailability have been ascribed traditionally to eNOS dysfunction. Whether nNOS 
dysfunction is potentially involved in impaired muscle 22 / OVOQ
  control with aging remains 
unexplored. 
Given that advanced aging might impact both nNOS and eNOS function possibly due to 
prominent oxidative stress that promotes NOS uncoupling and/or direct NO inactivation (21, 49, 
54, 58), we examined whether nNOS-derived control of skeletal muscle microvascular and 
contractile function is altered in old rats. The hypothesis was tested that, contrary to what was 
observed previously in young rats (12), selective nNOS inhibition in old rats would result in 
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attenuated or absent alterations in resting and contracting muscle blood flow, 2OV
 , PO2mv and 
submaximal force production, thus indicating impaired nNOS-mediated microvascular and 
contractile control with aging. 
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 Methods 
 
A total of 21 old (27-28 mo; body mass 614 ± 11 g) male Fisher 344 x Brown Norway 
(F344xBN) rats were used in the present study for measurements of PO2mv and muscle blood 
flow (phosphorescence quenching and radiolabeled microspheres, respectively; n = 11), force 
production (n = 6) and time-control experiments (n = 4). Rats were obtained from Charles Rivers 
Laboratories and maintained on a 12:12-h light-dark cycle with food and water provided ad 
libitum. The selected age represents senescent rats according to the life-span of the F344xBN 
rodent strain (38). The F344xBN rat has the distinct advantage of not acquiring many of the age-
related pathologies that proliferate in their highly inbred counterparts (40). Upon completion of 
the study, rats were euthanized with intra-arterial pentobarbital overdose (~50 mg/kg). All 
procedures described herein were conducted under the guidelines established by the National 
Institutes of Health and approved by the Institutional Animal Care and Use Committee of Kansas 
State University. 
 
Experimental design consideration 
 Comparison with young rats is facilitated using data from ref. 12. The rationale for this 
procedure is based on the IACUC stipulation that additional animals not be sacrificed for 
replication of data. In addition, direct comparison between old and young (12) animals is 
facilitated by the fact that both experimental groups underwent the exact same protocols and old 
and young animal experiments were temporally interdigitated. 
 
Surgical preparation 
 Rats were anesthetized initially with 5% isoflurane-O2 mixture and maintained on 2-3% 
isoflurane-O2. The caudal (tail) artery was isolated surgically and cannulated (PE-50; Intra-
Medic Tubing, Clay Adams Brand) for continuous monitoring of heart rate and mean arterial 
pressure (HR and MAP, respectively; Digi-Med BPA model 200) and infusion of the 
phosphorescent probe palladium meso-tetra (4-carboxyphenyl) porphyrin dendrimer (R2; 15 
mg/kg; Oxygen Enterprises). Blood from the tail artery catheter was sampled at the end of each 
experimental condition (control and selective nNOS inhibition with S-methyl-L-thiocitrulline; 
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SMTC) for the determination of arterial blood gases, pH, systemic hematocrit and plasma lactate 
(n = 11). For blood flow measurements, an additional catheter (PE-10 connected to PE-50) was 
placed in the ascending aorta via the right carotid artery to allow injection of differently 
radiolabeled microspheres into the aortic arch. Anesthetized rats were maintained on a heating 
pad to maintain core temperature at ~37-38°C as measured via rectal probe. 
 Isoflurane-O2 mixture inhalation was progressively discontinued after catheter placement 
procedures and rats were then kept under anesthesia with pentobarbital sodium (administered i.a. 
to effect). The level of anesthesia was monitored frequently via the toe-pinch and blink reflexes 
and supplemented as necessary. Overlying skin and fascia from the middorsal region of the rat 
were reflected surgically to expose the right spinotrapezius muscle. The muscle was moistened 
constantly throughout the surgery and experimental protocol via superfusion of Krebs-Henseleit 
bicarbonate-buffered solution (4.7 mM KCl, 2.0 mM CaCl2, 2.4 mM MgSO4, 131 mM NaCl and 
22 mM NaHCO3; equilibrated with 5% CO2 and 95% N2; pH 7.4; warmed to 37-38°C) and 
surrounding tissue was covered with Saran wrap (Dow Brands). Stainless steel electrodes were 
sutured to the rostral (cathode) and caudal (anode) regions of the spinotrapezius muscle for 
electrically induced contractions. Our laboratory has demonstrated previously that these surgical 
procedures do not alter the microvascular integrity and responsiveness of the spinotrapezius 
muscle (3). 
 
Experimental protocol 
 Two separate contraction bouts were performed under control (1.2 ml heparinized saline) 
and selective nNOS inhibition (2.1 µmol/kg SMTC dissolved in 1.2 ml heparinized saline) 
conditions. This dose of SMTC was selected based on previous studies designed to inhibit 
selectively nNOS in both humans and rodents (18, 30, 53, 64) and our analysis of the highest 
possible SMTC dose that could be administered without affecting the hypotensive response to 
acetylcholine (indicative of non-specific eNOS inhibition; refs. 12, 13). Each solution was 
infused at a rate of 0.2 ml/min into the tail artery catheter for a total time of 6 min, after which a 
~2 min period was allowed for resting muscle PO2mv to stabilize. Subsequently, 1 Hz twitch 
contractions (~7 V, 2 ms pulse duration) were evoked via a stimulator (model s48; Grass 
Technologies) for 3 min. The muscle was then allowed to recover for a minimum of 25 min 
before the next condition was initiated (stimulation parameters held constant). Due to its 
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relatively long half-life (~40 min; refs. 18, 64), SMTC was always the last condition in order to 
prevent residual effects on vascular and skeletal muscle function. Importantly, there is no 
ordering (priming) effect on the PO2mv response to muscle contractions when a minimum of 20 
min of recovery is allowed between stimulations (7, 16). 
 
Effects of SMTC and L-NAME on the hypotensive responses to acetylcholine 
 In a subset of animals (n = 8 of 21 total rats), rapid acetylcholine infusions (5 µg/kg in 
0.2 ml of heparinized saline) were performed under control and SMTC conditions as well as after 
non-selective NOS inhibition with N
G
-nitro-L-arginine-methyl-ester (L-NAME; 10 mg/kg) 
administered into the caudal artery. The hypotensive responses to these infusions were recorded 
via the carotid artery catheter to confirm the efficacy of selective nNOS inhibition with SMTC 
(12, 13). 
 
Measurement of PO2mv 
 PO2mv was measured by phosphorescence quenching using a Frequency Domain 
Phosphorometer (PMOD 5000; Oxygen Enterprises). As described in detail previously (6), this 
method applies the Stern-Volmer relationship (51) which describes quantitatively the O2 
dependence of the phosphorescent probe (i.e., R2) via the following equation: 
 
)/(]1)/[(2   QkmvPo  
 
where Qk  is the quenching constant and   and   are the phosphorescence lifetimes in the 
absence of O2 and at the ambient O2 pressure, respectively. The   of phosphorescence decay 
was determined using 10 scans (100 ms) in the single-frequency mode. The phosphorescent 
probe R2 (   = 601 µs and Qk  = 409 mmHg
-1.
s
-1
 at pH = 7.4 and temperature 38°C) (51, 63) 
was infused approximately 15 min before initiation of muscle contractions. R2 is bound to 
albumin and is distributed uniformly in the plasma, thus providing a signal corresponding to the 
volume-weighted O2 pressure within the microvascular compartment (i.e., mainly the PO2 within 
the capillaries, which volumetrically constitutes the major intramuscular space) (48). The 
negative charge of the R2 probe also facilitates its restriction to the intravascular space (46). 
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 The common end of the light guide was placed ~2-4 mm superficial to the dorsal surface 
of the exposed right spinotrapezius muscle. The phosphorometer modulates sinusoidal excitation 
frequencies between 100 Hz and 20 kHz and allows phosphorescence lifetime measurements 
from 10 µs to ~ 2.5 ms. The excitation light (524 nm) was focused on a randomly-selected area 
of ~2 mm diameter within the central region of the exposed muscle and has a penetration depth 
of ~500 µm. PO2mv was measured continuously and recorded at 2 s intervals throughout the 
duration of the experimental protocols. 
 
Analysis of PO2mv kinetics 
 The kinetics of PO2mv were described by nonlinear regression analysis using the 
Marquardt-Levenberg algorithm (SigmaPlot 11.2; Systat software) for the onset of contractions. 
Transient PO2mv responses were fit with either a one- or two-component model: 
 
One component: 
)1( /)(2)(2)(2
TDt
BLt emvPOmvPOmvPO
  
 
Two-component:  
)1()1( 2
/)2(
22
1/)1(
21)(2)(2
 TDtTDt
BLt emvPOemvPOmvPOmvPO
   
 
where PO2mv(t) is the PO2mv at a given time t, PO2mv(BL) corresponds to the pre-contracting 
resting PO2mv, Δ1 and Δ2 are the amplitudes for the first and second components, respectively, 
TD1 and TD2 are the independent time delays for each component, and τ1 and τ2 are the time 
constants (i.e., time to reach 63% of the response) for each component. Goodness of fit was 
determined using three criteria: 1) the coefficient of determination; 2) the sum of squared 
residuals; and 3) visual inspection. 
The amplitude of the first component was normalized to its time constant (Δ1PO2mv/τ1) 
in order to provide an index of the relative rate of PO2mv fall. The overall time necessary to 
attain 63% of the final amplitude of the PO2mv response following contractions onset was 
determined independent of modeling procedures (T63; ref. 34) to ensure appropriateness of the 
model fits. 
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 The mean response time (MRT; ref. 43) was employed to describe the overall dynamics 
of the PO2mv response: 
 
11  TDMRT  
 
where TD1 and τ1 are defined above. The MRT analysis was constrained to the first phase of the 
PO2mv response since inclusion of the emergent second phase underestimates the actual rate of 
PO2mv fall following initiation of contractions (25). 
 The area under the PO2mv curve plotted as function of time (PO2AREA; ref. 23) was 
calculated during the 3 min contraction protocol to provide an index of the overall muscle 
microvascular oxygenation (i.e., incorporating resting and contracting steady-state PO2mv, time 
delays, amplitudes and time constants of the response to yield a value expressed in mmHg.s). 
 
Measurement of blood flow 
 Spinotrapezius muscle blood flow was measured using the radiolabeled microsphere 
technique, as described in detail previously (44). In each condition (control and SMTC), the 
stimulated right and non-stimulated left spinotrapezius muscles represented the contracting and 
resting blood flow measurements, respectively. Briefly, the tail artery catheter was connected to 
a 1 ml syringe, and blood withdrawal at a constant rate of 0.25 ml/min was performed via a 
Harvard pump (model 907). Differently radiolabeled microspheres (
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Sc or 
85
Sr; 15 µm diameter; 
Perkin Elmer Life and Analytical Sciences) were injected in random order into the aortic arch via 
the carotid artery catheter during the contracting steady-state (i.e., ~3 min after onset of 
stimulation). Upon completion of the experiment, the right and left spinotrapezius muscles, right 
and left kidneys and organs of the splanchnic region (stomach, adrenals, spleen, pancreas, small 
intestine, large intestine and liver) were carefully dissected, removed and weighed immediately 
after euthanasia. The thorax was opened and placement of the carotid artery catheter into the 
aortic arch was confirmed by anatomic dissection. Tissue radioactivity was determined on a 
gamma scintillation counter (Auto Gamma Spectrometer, Cobra model 5003; Hewlett-Packard), 
and blood flow was determined by the reference sample method (31) and expressed as 
ml/min/100 g of tissue. Adequate mixing of the microspheres was verified for each injection by 
demonstrating a <15% difference in blood flow between the right and left kidneys. Blood flow 
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data were also normalized to MAP and expressed as vascular conductance (VC; 
ml/min/100g/mmHg). 
 
Calculation of muscle 2OV
  
 Muscle 2OV
  was calculated from PO2mv and blood flow measurements as described 
previously (12, 27). Briefly, arterial O2 concentration (CaO2) was calculated directly from 
arterial blood samples, whereas venous O2 concentration (CvO2) was estimated from either the 
baseline (rest) or the contracting steady-state (contractions) PO2mv using the rat O2 dissociation 
curve (Hill coefficient of 2.6), the measured Hb concentration, a P50 of 38 mmHg and an O2 
carrying capacity of 1.34 ml O2/g Hb (1). The measures of the resting and contracting 
spinotrapezius blood flow ( mQ ) were then used to determine 2OV  via the Fick equation [i.e., 
)( 222 CvOCaOmQOV 
 ]. 
 
Measurement of submaximal muscle force production 
 The caudal end of the spinotrapezius muscle was exteriorized and sutured to a swivel 
apparatus and a non-distensible light-weight (0.4 g) cable, which linked the muscle to a force 
transducer (model FTO3; Grass Technologies). The preload tension was set at ~0.04 N to elicit 
the optimal length of the muscle for twitch force production (12, 27). Muscle force production 
was measured throughout control and SMTC contraction bouts which were identical to the 
contraction protocols described above for the measurement of PO2mv and blood flow. Force 
production was expressed as N/g muscle. 
 
Time-control experiments 
 The stability and reproducibility of the spinotrapezius muscle preparation has been 
addressed previously (12, 27) and was reconfirmed in the current study via time-control 
experiments (i.e., 2 control contraction bouts performed as described above). The average 
coefficient of variation for PO2mv kinetics and muscle force production was 9 ± 5% with no 
ordering effects (p>0.05). These data provide confidence that the significant effects (or lack 
thereof) detected herein were the direct result of selective nNOS inhibition with SMTC. 
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Statistical analyses 
 Data comparison was performed using paired Student’s t-tests, one-way repeated 
measures analysis of variance (ANOVA) or two-way repeated measures ANOVA where 
appropriate. Post hoc analyses were performed with the Student-Newman-Keuls test when a 
significant F ratio was detected. The z-statistic was calculated to determine differences from 
zero. The significance level was set at p<0.05. Results are reported as mean ± SE. 
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 Results 
 
Blood sampling, hemodynamic variables and Ach injections 
 There were no differences in arterial blood O2 saturation (control: 95.3 ± 0.2; SMTC: 
94.4 ± 0.7%), pH (control: 7.41 ± 0.01; SMTC: 7.40 ± 0.01), lactate concentration (control: 1.0 ± 
0.1; SMTC: 1.1 ± 0.1 mM) and systemic hematocrit (control: 35.6 ± 0.6; SMTC: 34.8 ± 0.6%) 
between conditions (p>0.05 for all). 
 The HR and MAP responses during control and SMTC conditions are displayed in Table 
3.1. HR and MAP did not change during the control saline infusion whereas MAP increased and 
HR decreased during the infusion of SMTC. Within each condition, there were no significant 
differences between rest (post-infusion) and contractions (steady-state). 
 The hypotensive responses to acetylcholine infusion during control, SMTC and L-NAME 
conditions are depicted in Fig. 3.1. The relative change in MAP with acetylcholine was not 
different between control and SMTC but decreased significantly with L-NAME. Similarly, the 
time to 50% recovery from the drop in MAP with acetylcholine was not different between 
control and SMTC but speeded significantly with L-NAME. These data are consistent with the 
notion that SMTC did not impair eNOS function in the present study. 
 
Spinotrapezius PO2mv 
 Mean spinotrapezius muscle PO2mv during control and SMTC infusions are shown in 
Fig. 3.2. The control infusion did not change PO2mv (pre-infusion: 36.1 ± 1.2; post-infusion: 
37.4 ± 1.3 mmHg; p>0.05) whereas SMTC infusion increased PO2mv from 35.3 ± 1.6 to 41.9 ± 
2.2 mmHg (p<0.05). PO2mv was not different between control and SMTC at the start or during 
the first 5 min of infusion (p>0.05) but was increased significantly by the end of SMTC infusion. 
 Mean spinotrapezius muscle PO2mv following the onset of contractions during control 
and SMTC conditions are shown in Fig. 3.3 and average kinetics parameters displayed in Table 
3.2. Although the time delay of the PO2mv fall following the onset of contractions (TD1; p<0.05) 
was reduced, SMTC did not change the PO2mv time constant (τ1; p>0.05). Furthermore, no 
differences in the overall dynamics of PO2mv as represented by the MRT (model dependent), T63 
(model independent) and Δ1PO2mv/τ1 (relative rate of PO2mv fall) were observed between 
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conditions (p>0.05 for all). SMTC did, however, increase the amplitude of the PO2mv fall during 
contractions (Δ1PO2mv; p<0.05) such that the contracting steady-state PO2mv (PO2mv(SS); 
p>0.05) was not different between conditions. Although SMTC elevated resting PO2mv, the 
overall muscle microvascular oxygenation during contractions as represented by the PO2AREA 
was not significantly different between conditions. 
 
Spinotrapezius blood flow and 2OV
  
 At rest, blood flow (Fig. 3.4, top left panel) and VC (control: 0.09 ± 0.02; SMTC: 0.07 ± 
0.01 ml/min/100g/mmHg; p>0.05) were not different between control and SMTC. During 
contractions, blood flow (Fig. 3.4, top right panel) was not different whereas VC (control: 1.01 ± 
0.09; SMTC: 0.82 ± 0.08 ml/min/100g/mmHg; p<0.05) was reduced with SMTC compared to 
control. Accordingly, SMTC did not alter the change in blood flow from rest to contractions 
(Δblood flow; control: 98.0 ± 9.1; SMTC: 97.1 ± 10.8 ml/min/100g; p>0.05) but attenuated the 
change in VC during the rest-contraction transient (ΔVC; control: 0.92 ± 0.09; SMTC: 0.75 ± 
0.07 ml/min/100g/mmHg; p<0.05). 
 Relative to the control condition, SMTC reduced significantly resting but not contracting 
spinotrapezius muscle 2OV
  (Fig. 3.4, bottom panels). However, from rest to contractions the 
change in muscle 2OV
  was not different between conditions (Δ 2OV ; control: 10.5 ± 1.0; SMTC: 
10.2 ± 1.5 ml/min/100g; p>0.05). 
 
Spinotrapezius muscle force production 
 As illustrated in Fig. 3.5, mean spinotrapezius muscle force production throughout the 
contraction protocol and the force-time integral were not significantly different between control 
and SMTC conditions. Similarly, the average steady-state force production-to- 2OV
  ratio was 
also unaffected by SMTC (force/ 2OV
 ; control: 0.024 ± 0.001; SMTC: 0.023 ± 0.001 N/ml 
O2/min; p>0.05). 
 
Abdominal organ blood flow and VC 
The effects of SMTC on resting blood flow and VC in the kidneys and organs of the 
splanchnic region are displayed in Table 3.3. Relative to control, SMTC decreased blood flow in 
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the kidneys, stomach, adrenals, spleen and large intestine (p<0.05 for all). SMTC decreased VC 
in the kidneys, stomach, adrenals, spleen, pancreas, small intestine and large intestine (p<0.05 
for all). 
52 
 
 Discussion 
 
The present investigation determined the effects of selective nNOS inhibition on skeletal 
muscle function at rest and during contractions in old rats. The principal novel finding was that 
the changes in contracting muscle blood flow, 2OV
 , PO2mv kinetics and submaximal force 
production produced by nNOS-inhibition in healthy young rats (12) were absent in old rats (see 
Fig. 3.6). Specifically, selective nNOS inhibition in old rats resulted in 1) alterations in resting 
muscle 2OV
  (↓23%) and PO2mv (↑18%) but not blood flow; 2) no changes in steady-state blood 
flow, 2OV
  or PO2mv during contractions; 3) no changes in the overall dynamics of PO2mv 
following the onset of contractions; and 4) no changes in muscle force production. These data 
suggest that nNOS-mediated control of contracting skeletal muscle microvascular and contractile 
function is altered in old rats. 
 
Effects of selective nNOS inhibition on skeletal muscle function in old rats 
Skeletal muscle PO2mv is dictated by the dynamic 22 / OVOQ
  matching within the 
microvascular space (6). We reported recently that selective nNOS inhibition with SMTC in 
healthy young rats increased resting spinotrapezius PO2mv via reductions in 2OV
  concomitant 
with no alterations in muscle blood flow (12). In the present study, similar effects were observed 
following SMTC infusion in old rats (Figs. 3.2 and 3.4, Table 3.2), thus suggesting that nNOS-
mediated function is preserved within aged skeletal muscle at least at rest. The lack of an effect 
of SMTC on resting skeletal muscle blood flow in both young (12) and old (Fig. 3.4, top left 
panel) anesthetized rats contrasts with that seen previously in the human forearm (53) and awake 
rat hindlimb (13) circulations. The reasons for this discrepancy are not entirely clear but could 
relate partially to the effects of anesthesia. However, the reductions in blood flow to the kidneys 
and organs of the abdominal region following SMTC infusion in old rats at rest (Table 3.3) are 
consistent with the role of nNOS-derived NO in regulating renal and splanchnic blood flow as 
reported previously in the awake young rat at rest (13, see also refs. 30, 32). These findings also 
suggest preserved nNOS-mediated function in the renal and splanchnic circulations with aging at 
rest. 
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 The SMTC-induced reductions in resting spinotrapezius 2OV
  in both young (12) and old 
(Fig. 3.4, bottom left panel) rats are surprising considering the well-known inhibitory effects of 
NO on mitochondrial respiration (56) that may actually act to increase resting muscle 2OV
  
following non-selective NOS inhibition (e.g., dogs, ref. 20, human, ref. 22). Although our data 
could be interpreted as reflecting a stimulatory role of NO from nNOS on mitochondrial 
respiration (66; see also refs. 4, 37) and/or relate to possible differences in NOS isoform 
compartmentalization across species, evidence from isolated cardiac muscle suggests rather that 
nNOS-derived NO does not control directly tissue 2OV
  (35, 41). In the latter scenario, reduced 
resting 2OV
  with SMTC in old rats could result from blockade of uncoupled nNOS which 
alleviates the inactivation of NO from eNOS and restores partially mitochondrial respiratory 
inhibition (cf. 35). These intriguing possibilities remain to be tested empirically in aged skeletal 
muscle. 
 Despite the apparent preserved contribution of nNOS-derived NO to resting skeletal 
muscle function with aging (as discussed above), the effects of SMTC on contracting muscle 
blood flow, 2OV
 , PO2mv kinetics and force production observed presently in old rats differ 
markedly from those reported previously in young rats (12). Specifically, selective nNOS 
inhibition in young rats 1) reduced contracting steady-state muscle blood flow and 2OV
 ; 2) 
speeded the fall in PO2mv following the onset of contractions (i.e., shorter MRT, T63 and 
Δ1PO2mv/τ1); and 3) increased submaximal force production (12). In old rats, however, SMTC 
had no significant effects on any of these variables during muscle contractions (Table 3.2, Figs. 
3.4 and 3.5). Figure 3.6 summarizes these results and illustrates the contrasting effects of SMTC 
on skeletal muscle hemodynamic, metabolic and contractile function in young (12) compared 
with old (present study) rats during contractions. These data thus suggest that nNOS-mediated 
regulation of skeletal muscle microvascular and contractile function during transitions in 
metabolic demand is altered with advanced aging. 
 Alterations in nNOS-mediated regulation of skeletal muscle during contractions, but not 
at rest, with aging could emanate from age-related disruptions in myocyte redox state. Enhanced 
reactive oxygen and nitrogen species accumulation during muscle contractions (2, 8) coupled 
with impaired antioxidant mechanisms in old individuals (65) may exacerbate the underlying 
oxidative stress characteristic of aging (17) and promote nNOS uncoupling and/or direct NO 
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inactivation (21, 49, 58). This leads to reduced nNOS-derived NO bioavailability which likely 
impacts contracting skeletal muscle microvascular and contractile function via multiple 
mechanisms. Specifically, considerable evidence in young subjects suggests critical regulatory 
roles for NO derived from nNOS on contracting muscle blood flow (via cGMP formation and/or 
functional sympatholysis; refs. 15, 39, 60), 2OV
  (contribution to oxidative enzyme inertia at 
contractions onset; e.g., ref. 34) and, therefore, PO2mv kinetics (12). In addition, nNOS-derived 
NO bioavailability likely modulates submaximal force production via inhibitory influences on 
myofibrillar contractile elements (36). 
 
Clinical implications 
 Understanding how aging impacts the functional role of nNOS-derived NO on skeletal 
muscle represents the initial step towards the development of potential therapeutic strategies 
targeting this isoform. Utilization of isoform selective NOS inhibitors is therefore crucial in such 
investigations. As discussed in detail elsewhere (12, 13) and demonstrated by previous 
pharmacological studies (18, 64) and the current hypotensive responses to Ach (Fig. 3.1), SMTC 
represents a viable tool for this purpose based on its selectivity for nNOS over both eNOS and 
iNOS inhibition. Acute selective pharmacological inhibition as utilized herein also minimizes the 
potential for chronic compensation of genetically modified nNOS models by other isoforms (33). 
 It is noteworthy that alterations in skeletal muscle nNOS expression and/or activity with 
aging (9, 11, 50, 55) may not predict nNOS-mediated function particularly in conditions 
associated with significant oxidative stress (e.g., aging, chronic heart failure and diabetes), which 
promotes nNOS uncoupling and/or direct NO inactivation (21, 49, 58). Our current results 
therefore suggest that nNOS-mediated regulation of skeletal muscle microvascular and 
contractile function is altered in old individuals. Important clinical implications arise from these 
findings when considering that endurance exercise training could improve nNOS-mediated 
function via upregulation of nNOS expression and/or activity (55) in conjunction with 
augmented antioxidant capacity (62). 
 Besides its effects on nNOS-mediated function, it is important to acknowledge that 
advanced age results in downregulation of eNOS alongside upregulation of iNOS which is 
consistent with a greater role for NO in inflammatory processes and a reduced participation in 
contractile function in aged skeletal muscle (55). This shift in the muscle NOS isoform profile 
55 
 
with aging is hallmarked by oxidative stress and endothelial dysfunction (14, 24, 26, 54, 59, 61, 
65) which likely contribute to exercise intolerance in this population (47). 
 
Experimental considerations 
In view of the greater relative expression and activity of nNOS in fast-twitch compared to 
slow-twitch muscles (36, 39), potential alterations in skeletal muscle fiber type composition with 
aging could partly underlie the responses seen herein following SMTC. However, it must be 
noted that potential age-related shifts in muscle phenotype may not only favor an increased 
abundance of slow-twitch fibers as traditionally considered, but also promote alterations in the 
opposite direction (i.e., increased abundance of fast-twitch fibers) in both humans and animals 
(see ref. 10 for discussion). Despite these possibilities, F344xBN rats do not appear to experience 
significant changes in fiber type composition within representative skeletal muscles across the 
age range used herein (42). 
In accordance with the latter and the fact that F344xBN rats do not develop many of the 
age-related pathologies seen in their highly inbred counterparts (which is essential to discern 
healthy aging from pathological decay; ref. 40), the National Institutes of Health supports 
currently the use of the F344xBN rat as a model of aging. In the absence of evidence to the 
contrary, we therefore consider that these key facets outweigh any likely interspecies differences 
in nNOS-mediated control and thus facilitate comparison with young Sprague-Dawley rats (12) 
and suggest that differences in strain are unlikely to play a major role in the responses seen 
herein following selective nNOS inhibition with SMTC (Fig. 3.6). 
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 Conclusions 
 
Pharmacological isoform-specific NOS inhibition revealed that nNOS-mediated control 
of contracting skeletal muscle function is altered with advanced aging. In marked contrast to the 
responses seen previously in young rats (12), nNOS inhibition with SMTC evoked no alterations 
in contracting muscle blood flow, 2OV
 , PO2mv kinetics and submaximal force production in old 
rats (as illustrated in Fig. 3.6). These novel findings suggest that, in addition to the documented 
deterioration in eNOS function (e.g., refs. 54, 65), alterations in nNOS-mediated regulation of 
contracting skeletal muscle microvascular function with aging may contribute to reduced 
exercise capacity in this population. 
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Table 3.1 Heart rate (HR) and mean arterial pressure (MAP) before (control) and after 
selective nNOS inhibition with SMTC 
 Control SMTC 
At rest (pre-infusion)   
HR, bpm 297 ± 9 307 ± 4 
MAP, mmHg 109 ± 3 112 ± 3 
   
At rest (post-infusion)   
HR, bpm 305 ± 6 294 ± 4*† 
MAP, mmHg 111 ± 4 126 ± 3*† 
   
Contractions (steady-state)   
HR, bpm 309 ± 7 292 ± 6*† 
MAP, mmHg 107 ± 3 129 ± 3*† 
Values are mean ± SE. * p<0.05 vs. control. † p<0.05 vs. rest (pre-infusion). Within each 
condition, there were no significant differences between rest (post-infusion) and contractions 
(steady-state). 
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Table 3.2 Muscle PO2mv at rest and following the onset of contractions before (control) and 
after selective nNOS inhibition with SMTC 
 Control SMTC 
PO2mv(BL), mmHg 37.7 ± 1.2 44.2 ± 2.1* 
Δ1PO2mv, mmHg 12.4 ± 0.9 17.6 ± 2.1* 
Δ2PO2mv, mmHg 2.3 ± 0.2 2.6 ± 0.5 
ΔTotalPO2mv, mmHg 11.0 ± 0.7 17.2 ± 2.1* 
PO2mv(SS), mmHg 26.9 ± 1.3 27.3 ± 2.4 
TD1, s 10.1 ± 1.5 6.3 ± 0.7* 
TD2, s 73.1 ± 11.7 52.8 ± 14.5 
τ1, s 9.6 ± 0.9 13.7 ± 1.8 
τ2, s 59.5 ± 15.1 55.7 ± 4.7 
MRT, s 19.7 ± 1.5 20.0 ± 2.0 
T63, s 20.9 ± 1.9 19.6 ± 1.4 
Δ1PO2mv/τ1, mmHg/s 1.3 ± 0.1 1.4 ± 0.2 
PO2AREA, mmHg.s 4920 ± 244 5195 ± 402 
Values are mean ± SE. PO2mv(BL), pre-contracting PO2mv; Δ1PO2mv, amplitude of the first 
component; Δ2PO2mv, amplitude of the second component; ΔTotalPO2mv, overall amplitude 
regardless of one- or two-component model fit; PO2mv(SS), contracting steady-state PO2mv; TD1, 
time delay for the first component; TD2, time delay for the second component; τ1, time constant 
for the first component; τ2, time constant for the second component; MRT, mean response time; 
T63, time to reach 63% of the overall amplitude as determined independent of modeling 
procedures; Δ1PO2mv/τ1, relative rate of PO2mv fall; PO2AREA, area under the PO2mv curve over 
the 3 min contraction period. The two-component exponential model was used to analyze the 
PO2mv kinetics in the majority of instances (7 out of 11) in the control condition while the one-
component model was required to fit the SMTC response in most rats (9 out of 11). * p<0.05 vs. 
control. 
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Table 3.3 Resting blood flow and vascular conductance in the kidneys and organs of the 
splanchnic region before (control) and after selective nNOS inhibition with SMTC 
 
Blood flow, 
ml/min/100g 
 
Vascular conductance, 
ml/min/100g/mmHg 
 Control SMTC  Control SMTC 
Kidneys 515 ± 52 319 ± 25*  4.88 ± 0.57 2.49 ± 0.19* 
Stomach 55 ± 7 34 ± 2*  0.52 ± 0.08 0.27 ± 0.02* 
Adrenals 798 ± 75 542 ± 55*  7.47 ± 0.72 4.20 ± 0.39* 
Spleen 256 ± 28 217 ± 26*  2.43 ± 0.29 1.72 ± 0.21* 
Pancreas 105 ± 19 101 ± 26  0.98 ± 0.16 0.76 ± 0.17* 
Small intestine 342 ± 37 290 ± 18  3.24 ± 0.40 2.27 ± 0.17* 
Large intestine 116 ± 8 95 ± 5*  1.09 ± 0.08 0.75 ± 0.05* 
Liver † 23 ± 3 25 ± 5  0.21 ± 0.03 0.19 ± 0.04 
Values are mean ± SE. † Designates arterial, not portal blood flow and vascular conductance. * 
p<0.05 vs. control. 
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Figure 3.1 Effects of SMTC and L-NAME on the hypotensive responses to acetylcholine 
 
 
Figure 3.1 Effects of selective nNOS inhibition (SMTC) and non-selective NOS inhibition (L-
NAME) on the hypotensive responses to acetylcholine. Top and bottom panels depict the relative 
drop in mean arterial pressure (MAP) and time to 50% recovery from the hypotensive response 
to acetylcholine, respectively. * p<0.05 vs. control and SMTC. 
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Figure 3.2 Muscle PO2mv during infusion of saline or SMTC 
 
 
Figure 3.2 Mean resting spinotrapezius muscle PO2mv during infusion of saline (control) or 
SMTC (selective nNOS inhibition). Time zero denotes start of infusion. * p<0.05 vs. control for 
end-infusion PO2mv (last 10 s average). 
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Figure 3.3 Muscle PO2mv at rest and following the onset of contractions under control and 
SMTC conditions 
 
 
Figure 3.3 Mean spinotrapezius muscle PO2mv at rest and following the onset of contractions 
under control and selective nNOS inhibition (SMTC) conditions. Time zero denotes the onset of 
muscle contractions. Average kinetics parameters are displayed in Table 3.2. See text for further 
details. 
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Figure 3.4 Muscle blood flow and O2 utilization at rest and during contractions under 
control and SMTC conditions 
 
 
 
Figure 3.4 Mean spinotrapezius muscle blood flow (top panels) and O2 utilization ( 2OV
 ; bottom 
panels) at rest and during contractions under control and selective nNOS inhibition (SMTC) 
conditions. Note different scales on vertical axes.* p<0.05 vs. control. 
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Figure 3.5 Muscle force production under control and SMTC conditions 
 
 
Figure 3.5 Mean spinotrapezius muscle force production under control and selective nNOS 
inhibition (SMTC) conditions. Note that muscle force production was not significantly different 
throughout the contraction period between control and SMTC. The inset shows that force-time 
integral values were also not significantly different between conditions. 
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Figure 3.6 Effects of SMTC on contracting muscle blood flow, 2OV

, PO2mv kinetics and 
force production in young and old rats 
 
 
Figure 3.6 Effects of selective nNOS inhibition (SMTC) on contracting spinotrapezius muscle 
blood flow, O2 utilization ( 2OV
 ), overall PO2mv kinetics (MRT, mean response time) and 
submaximal force production in young Sprague-Dawley (data from ref. 12; n = 10) and old 
F344xBN (present study; n = 11) rats. Note that SMTC evoked significant changes in these 
variables in young but not old rats. * p<0.05 vs. zero. See text for discussion. 
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Chapter 4 - Acute effects of hydrogen peroxide on skeletal muscle 
microvascular oxygenation from rest to contractions 
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 Summary 
 
Reactive oxygen species such as hydrogen peroxide (H2O2) exert a critical regulatory role 
on skeletal muscle function. Whether acute increases in H2O2 modulate muscle microvascular O2 
delivery-utilization ( 2OQ
 / 2OV ) matching (i.e., microvascular partial pressure of O2; PO2mv) at 
rest and following the onset of contractions is unknown. The hypothesis was tested that H2O2 
treatment (exogenous H2O2) would enhance PO2mv and slow PO2mv kinetics during contractions 
compared to control. Anesthetized healthy young Sprague-Dawley rats had their spinotrapezius 
muscles either exposed for measurement of blood flow (and therefore 2OQ
 ), 2OV  and PO2mv or 
exteriorized for measurement of force production. Electrically stimulated twitch contractions (1 
Hz, ~7 V, 2 ms pulse duration, 3 min) were evoked following acute superfusion with Krebs-
Henseleit (control) and H2O2 (100 µM). Relative to control, H2O2 treatment elicited 
disproportionate increases in 2OQ
  and 2OV  that elevated PO2mv at rest and throughout 
contractions and slowed overall PO2mv kinetics (i.e., ~85% slower mean response time; P<0.05). 
Accordingly, H2O2 resulted in ~33% greater overall microvascular oxygenation as assessed by 
the area under the PO2mv curve (P<0.05). Muscle force production was not altered with H2O2 
treatment (P>0.05), evidencing reduced economy during contractions (~40% decrease in the 
force/ 2OV
  relationship; P<0.05). These findings indicate that, although increasing the driving 
force for blood-myocyte O2 flux (i.e., PO2mv), transient elevations in H2O2 impair skeletal 
muscle function (i.e., reduced economy during contractions) which mechanistically may 
underlie, in part, the reduced exercise tolerance in conditions associated with oxidative stress. 
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 Introduction 
 
Reactive oxygen species (ROS) are pivotal elements in signal transduction (8, 20, 21, 46, 
56). Hydrogen peroxide (H2O2), a small diffusible and ubiquitous molecule with a long half-life 
relative to other ROS, is regarded as one of the most influential ROS in terms of redox signaling 
(21). H2O2 is generated constantly within skeletal muscle and its vasculature via direct reduction 
of molecular O2 (e.g., by NADPH oxidase, xanthine oxidase and uncoupled nitric oxide (NO) 
synthases) or dismutation of superoxide radicals either spontaneously or enzymatically by 
superoxide dismutase (SOD) (8, 46, 56). Key scavengers of H2O2 include the enzymes catalase, 
glutathione peroxidase and peroxiredoxin (8, 46, 56). 
Alterations in H2O2 bioavailability have important implications for skeletal muscle 
function at rest and during metabolic transients. Transient elevations in H2O2 levels could 
mediate an initial compensatory response to acute oxidative stress (traditionally defined as a 
disturbance in the oxidant-antioxidant balance in favor of the former) by acting as an 
endothelium-derived hyperpolarizing factor (EDHF; refs. 34, 51) and/or increasing endothelial 
NO synthase (eNOS) activity (12, 27, 63, 64), therefore minimizing potential deleterious effects 
on vasomotor control (15, 35, 43). Consistent with this notion, Csekő et al. (16) reported that 
exogenously applied H2O2 promotes concentration- and time-dependent effects on skeletal 
muscle arteriolar tone (and by implication O2 delivery; 2OQ
 ). At 100 µM concentration, there is 
a biphasic effect composed of a brief constriction followed by a vasodilation that reaches steady-
state within approximately 3 min. In addition to its effects on the vasculature, acute increases in 
H2O2 also modulate skeletal muscle O2 utilization ( 2OV
 ; ref. 57) and contractile function (4, 37, 
49, 55). Exposure of isolated skeletal muscle mitochondria to H2O2 (100 µM) uncouples 
oxidative phosphorylation and reduces energy transfer efficiency (expected to result in relatively 
greater muscle 2OV
 ) (57). Brief application of exogenous H2O2 (~100 µM) increases force 
production in isolated unfatigued skeletal muscle fibers (49). However, whether acute redox state 
modulation via increased H2O2 improves the dynamic matching between skeletal muscle 2OQ
  
and 2OV
  (i.e., enhanced muscle microvascular oxygenation; PO2mv) at rest and during 
contractions is unknown. Resolution of this issue is important given that, as dictated by Fick’s 
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law of diffusion, low PO2mv impairs blood-myocyte O2 flux and consequently dysregulates 
skeletal muscle metabolism (26), an effect that could impact negatively upon contractile 
performance in oxidative stress conditions such as aging, chronic heart failure, hypertension and 
diabetes. 
The present study examined the effects of acutely increased H2O2 on muscle 
microvascular oxygenation (PO2mv) and force production following the onset of contractions in 
healthy rat skeletal muscle in situ. Aiming to gain insights into how brief H2O2 exposure 
modulates the 2OQ
 / 2OV  ratio and therefore PO2mv, we also determined resting and contracting 
steady-state 2OQ
  and 2OV  responses. Based on the evidence summarized above, the hypotheses 
were tested that acute oxidant treatment (exogenous 100 µM H2O2) would increase (i) blood 
flow (and thus 2OQ
 ) and 2OV ; (ii) PO2mv and slow PO2mv kinetics during contractions and (iii) 
muscle force production. 
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 Methods 
 
Animals 
A total of 43 young male Sprague-Dawley rats (3-4 months old; body mass 354 ± 13 g) 
were used in the present study for measurements of PO2mv (phosphorescence quenching; n = 
20), muscle blood flow (radiolabelled microspheres; n = 13) and force production (n = 10). Rats 
were obtained from Charles River Laboratories and maintained on a 12:12-h light-dark cycle 
with food and water provided ad libitum. Upon completion of the study, all rats were euthanized 
with pentobarbital sodium overdose. All experimental procedures were conducted under the 
guidelines established by the National Institutes of Health and approved by the Institutional 
Animal Care and Use Committee of Kansas State University. 
 
Surgical preparation 
Animals were anesthetized initially with 5% isoflurane gas. Subsequently, while being 
maintained on a 2-3% isoflurane-O2 mixture, the caudal (tail) artery was isolated surgically and 
cannulated (PE-10 connected to PE-50; Intra-Medic Tubing, Clay Adams Brand) for continuous 
monitoring of mean arterial pressure (MAP; Digi-Med BPA model 200) and infusion of the 
phosphorescent probe palladium meso-tetra (4-carboxyphenyl) porphyrin dendrimer (R2; 15 
mg/kg; Oxygen Enterprises). Blood from the tail catheter was sampled at the end of each 
experimental protocol within a subset of ten animals for the determination of arterial blood 
gases, pH, systemic hematocrit and plasma lactate. For blood flow measurements, an additional 
catheter (PE-10 connected to PE-50) was placed in the ascending aorta via the right carotid 
artery to allow the injection of differently radiolabelled 15 µm diameter microspheres into the 
aortic arch as described previously (38). Anesthetized rats were kept on a heating pad to maintain 
core temperature, measured via rectal probe, at ~37-38 °C. 
 After catheter placement procedures, isoflurane inhalation was progressively 
discontinued and rats were kept under anesthesia with intra-arterial pentobarbital sodium 
throughout the experiment. The level of anesthesia was monitored frequently via the toe-pinch 
and blink reflexes and supplemented as necessary. Overlying skin and fascia from the mid-dorsal 
region of the rat was removed carefully to expose the spinotrapezius muscle. The muscle was 
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moistened constantly during the surgical preparation via superfusion of Krebs-Henseleit (K-H) 
bicarbonate-buffered solution (4.7 mM KCl, 2.0 mM CaCl2, 2.4 mM MgSO4, 131 mM NaCl and 
22 mM NaHCO3) equilibrated with 5% CO2 and 95% N2 at ~38 °C whereas surrounding tissue 
was covered with Saran Wrap (Dow Brands). Stainless steel electrodes were sutured to the 
rostral (cathode) and caudal (anode) regions of the spinotrapezius muscle for electrically-induced 
contractions. We have previously demonstrated that these surgical procedures do not alter the 
microvascular integrity and responsiveness of the spinotrapezius muscle (9). 
 
Experimental protocol 
 Two separate contraction bouts were performed under control (3 mL K-H) and H2O2 (100 
µM in 3 mL K-H) superfusion conditions. This concentration was selected based on previous 
studies in which similar exogenous H2O2 concentrations impacted significantly rat skeletal 
muscle arteriolar tone (16), mitochondrial respiration (57) and force production (49). Given that 
intracellular H2O2 reaches a value that is approximately an order of magnitude lower than that of 
the applied exogenous concentration (6), our experimental protocol was expected to elevate 
acutely H2O2 to those levels measured in the early stages of senescence and cardiovascular 
diseases (i.e., from ~10 µM in the healthy young rat skeletal muscle interstitial fluid and 
mesenteric artery in vivo to ~20-40 µM in conditions such as hypertension; refs. 59, 63, 64). Also 
relevant in this regard is that exposure of isolated skeletal muscle fibers to 100 µM H2O2 does 
not produce gross histological damage (41, see also ref. 47). Exogenous H2O2 treatment does not 
produce oxidative damage to hemoglobin in intact red blood cells (12.5-100 µM; refs.33, 39) or 
myoglobin in isolated skeletal muscle (1 mM; ref. 19). Due to its time-dependent actions on 
eNOS and NADPH oxidase activity (12, 27), H2O2 was the last treatment to prevent residual 
long-term effects on vascular and skeletal muscle function. 
The experimental protocol is illustrated in Fig. 4.1. The spinotrapezius muscle was 
superfused with each solution (average flow rate ~2 mL/min) for a total time of ~1.5 min, after 
which a 3 min incubation period followed to allow arteriolar vasodilation (and consequently 
2OQ
  and PO2mv) to reach steady-state under H2O2 treatment based on data from Csekő et al. 
(16) and preliminary studies from our laboratory (Hirai DM, Copp SW, Schwagerl PJ, Musch TI, 
Poole DC; unpublished data). Subsequently, electrical stimulation (1 Hz, ~7 V, 2 ms pulse 
duration) of the muscle was evoked via a Grass Stimulator (model s48) for 3 min. The muscle 
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was then allowed to recover for ~25 min before the next condition was initiated (stimulation 
parameters were held constant). 
 The spinotrapezius preparation exhibits reproducible PO2mv kinetic parameters during 
transitions in metabolic demand evoked by 1 Hz twitch contractions when a minimum of 20 min 
of recovery is allowed between contraction bouts (14, 23). Accordingly, highly reproducible 
overall PO2mv kinetics (mean response time; MRT) from repeated contraction bouts separated 
by ~25 min were obtained herein (within-animal coefficient of variation: 3 ± 2 s; n = 6) with no 
ordering effect (overall within-animal difference: 1 ± 3 s; P>0.05). Moreover, the 25-30 min 
period between contractions (3 min off-transition, ~20 min recovery, ~1.5 min superfusion, 3 
min incubation; see Fig. 4.1) was employed herein to avoid any priming effect that might 
confound the experimental interpretation of the PO2mv responses to muscle contractions (11). 
 
Measurement of PO2mv 
 PO2mv was measured by phosphorescence quenching using a Frequency Domain 
Phosphorometer (PMOD 5000; Oxygen Enterprises). The principles of the phosphorescence 
quenching method have been discussed in detail previously (10). Briefly, this method applies the 
Stern-Volmer relationship (50), which describes quantitatively the O2 dependence of the 
phosphorescent probe (i.e., R2) via the following equation: 
 





Qk
mvPO
1)/(
2  
 
where Qk  is the quenching constant and   is the phosphorescence lifetime in an O2-free 
environment. The   of phosphorescence decay was determined using 10 scans (100 ms) in the 
single frequency mode (50, 61). The phosphor R2 ( 601 µs and 409Qk  mmHg
-1.s
-1
 at pH 
= 7.4 and temperature ~38 °C) was infused ~15 min prior to initiation of muscle contractions. 
The R2 probe is bound to albumin and is distributed uniformly in the plasma thus providing a 
signal corresponding to the volume-weighed O2 pressure in the microvascular compartment 
(mainly the PO2 within the capillaries, which volumetrically constitutes the major intramuscular 
space; ref. 45). In addition to albumin binding, the negative charge of the R2 probe also 
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facilitates its restriction to the intravascular space within the muscle (44). Data from Oter and 
Ribou (42) suggest that it is highly unlikely that our H2O2 treatment could affect oxygen 
measurements with probes such as metalloporphyrin complexes (e.g., R2). In fact, no 
interference is expected to occur in lifetime-based measurements using H2O2 concentrations 
lower than 0.1 M. 
The common end of the bifurcated light guide was placed 2-4 mm superficial to the 
dorsal surface of the exposed spinotrapezius muscle. The phosphorometer modulates sinusoidal 
excitation frequencies between 100 Hz and 20 kHz and allows phosphorescence lifetime 
measurements from 10 µs to approximately 2.5 ms. The excitation light (524 nm) was focused 
on a randomly selected area of ~2 mm diameter of exposed muscle and has a resulting 
penetration depth of ~500 µm which is somewhat less than the spinotrapezius muscle thickness 
in the region sampled. PO2mv was recorded at 2 s intervals throughout the duration of the 
experimental protocol (superfusion, incubation, electrical stimulation and recovery periods). 
 Movement of the light guide (or animal) was avoided so as to monitor the same sampling 
site throughout the entire experimental protocol. However, alteration of the PO2mv measurement 
plane during muscle contractions precluded kinetic curve fitting in some instances. Therefore, 
microvascular oxygenation results from the present study are presented from animals under the 
following conditions: control, n = 20; H2O2, n = 12. 
 
Analysis of PO2mv kinetics 
 The kinetics of PO2mv were described by nonlinear regression analysis using the 
Marquardt-Levenberg algorithm (SigmaPlot 9.01; Systat Software) for the onset of contractions. 
Transient PO2mv responses were fit with either a one- or two-component model (10): 
 
One-component: 
)1( /)(2)(2)(2
TDt
BLt emvPOmvPOmvPO
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Two-component: 
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where PO2mv(t) is the PO2mv at a given time t, PO2mv(BL) corresponds to the pre-contracting 
resting PO2mv, Δ1 and Δ2 are the amplitudes for the first and second components, respectively, 
TD1 and TD2 are the independent time delays for each component, and τ1 and τ2 are the time 
constants (i.e., time taken to achieve 63% of the response) for each component. Goodness of fit 
was determined using three criteria: (i) the coefficient of determination; (ii) the sum of squared 
residuals; and (iii) visual inspection. 
 The mean response time (MRT; ref. 31) was used to describe the overall dynamics of the 
PO2mv response: 
 
TDMRT  
 
where TD and τ are defined above. The MRT analysis was limited to the first phase of the 
PO2mv response since inclusion of the emergent second phase underestimates the actual rate of 
PO2mv fall following the onset of contractions (25). The overall time necessary to attain 63% of 
the final amplitude of the PO2mv response during the onset of contractions was determined 
independent of modeling procedures (T63; ref. 29) as an additional means of checking the 
accuracy of the model fits to the data. 
 The area under the PO2mv curve plotted as function of time (PO2AREA; ref. 24) was 
calculated during 3 min following the onset of contractions to provide an index of the overall 
muscle microvascular oxygenation throughout the exercise transient for each condition (i.e., 
incorporating resting and contracting steady-state PO2mv, time delays, amplitudes and time 
constants of the response to yield a value expressed in mmHg.s). 
 
Measurement of muscle blood flow 
 Spinotrapezius blood flow was measured using the radiolabelled microsphere technique 
as described in detail previously (38). In each condition (control and H2O2), the stimulated right 
and non-stimulated left spinotrapezius muscles represented the contracting and resting blood 
flow measurements, respectively (14, 23). Briefly, the tail artery catheter was connected to a 1 
mL syringe and blood withdrawal was initiated at a constant rate of 0.25 mL/min via a Harvard 
pump (model 907). Differentially radiolabelled 15 µm diameter microspheres (
46
Sc or 
85
Sr; 
Perkin Elmer Life and Analytical Sciences) were injected in random order into the aortic arch via 
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the carotid artery catheter during the contracting steady-state (i.e., ~3 min after initiation of 
muscle contractions). Upon completion of the experiment, the right and left spinotrapezius 
muscles and right and left kidneys were carefully dissected, removed and weighed immediately 
after euthanasia. The thorax was opened, and placement of the carotid artery catheter into the 
aortic arch was confirmed by anatomical dissection. 
 Tissue radioactivity was determined on a gamma scintillation counter (Packard Auto 
Gamma Spectrometer, Cobra model 5003) and muscle blood flow was determined by the 
reference sample method (28) and expressed as mL/min/100 g tissue. Adequate mixing of the 
microspheres was verified for each injection by demonstrating a <15% difference in blood flow 
between the right and left kidneys. 
 
Calculation of muscle 2OV
  
 Muscle 2OV
  was calculated from PO2mv and blood flow ( mQ ) measurements as 
described previously (14, 23). Briefly, arterial O2 concentration (CaO2) was calculated from 
arterial blood samples, while venous O2 concentration (CvO2) was calculated from both the mean 
resting or contracting steady-state PO2mv using the rat O2 dissociation curve (Hill coefficient of 
2.6), the measured hemoglobin (Hb) concentration, a PO2 at which hemoglobin is 50% saturated 
(P50) of 38 mmHg, and an O2 carrying capacity of 1.34 mL O2/g Hb (2). Mean resting and 
contracting steady-state spinotrapezius mQ ’s were then used to calculate muscle 2OV ’s via the 
Fick equation (i.e., )( 222 CvOCaOmQOV 
 ). Muscle 2OV  standard errors were estimated 
from mQ  measurements. 
 
Measurement of muscle force production 
The caudal end of the spinotrapezius muscle was exteriorized and sutured to a swivel 
apparatus and a non-distensible light weight (0.4 g) cable, which linked the muscle to a Grass 
force transducer (model FTO3). The preload tension of the muscle was set at ~4 g, which evoked 
the optimal length of the muscle for twitch force production (14, 23). Superfusion and 
contraction protocols were performed as described above. Force production was expressed as g/g 
muscle. 
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 Time-control experiments demonstrated excellent reproducibility of force production 
measurements (within-animal coefficient of variation: 1 ± 1 g/g muscle; i.e., ≤5%; n = 6) with no 
ordering effect (overall within-animal difference: 2 ± 1 g/g muscle; i.e., ≤10%; P>0.05) between 
two consecutive contraction bouts. Therefore, based on these findings and our previous reports 
demonstrating the stability and reproducibility of the spinotrapezius preparation (9, 14, 23), it is 
highly unlikely that fatigue and/or deterioration of the preparation per se could account for any 
changes (or lack thereof) in measured variables under different treatments. 
 
Statistical analyses 
 PO2mv and MAP data comparison was performed using unpaired Student’s t-tests. Blood 
flow, 2OV
  and force production data comparison was performed using ANOVA techniques. Post 
hoc analyses were performed with the Bonferroni test when a significant F-ratio was detected. 
The level of significance was set at P<0.05. Results are reported as mean ± standard error (SE). 
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 Results 
 
Arterial PO2 averaged 91.5 ± 2.3 mmHg, O2 saturation 89.0 ± 2.1 %, blood pH 7.38 ± 
0.01, systemic hematocrit 34.9 ± 0.7 % and plasma lactate 1.5 ± 0.1 mmol/L. 
 
Muscle microvascular oxygenation (PO2mv) 
 The control treatment did not change resting PO2mv (i.e., similar values before and after 
K-H superfusion and incubation periods, PO2mv(Pre) and PO2mv(Post); Table 4.1). Representative 
PO2mv profiles during K-H (control) and H2O2 superfusion and incubation periods are depicted 
in Fig. 4.2. A transient fall in PO2mv following H2O2 superfusion, consistent with the brief 
arteriolar constriction response reported by Csekő et al. (16) in isolated vessels exposed to 100 
µM H2O2, was observed in only 2 rats. Nonetheless, H2O2 treatment increased PO2mv in all 
cases beyond ~30 s. 
 The time course of PO2mv following the onset of contractions during H2O2 treatment 
presented significant quantitative differences relative to the control condition (Table 4.1 and Fig. 
4.3). The post-treatment resting PO2mv (PO2mv(Post)) was significantly higher for H2O2 compared 
with control. The one-component exponential model provided an excellent fit to the PO2mv data 
for the majority of instances (16 out of 20) in the control condition and in all profiles for H2O2. 
Within the different experimental treatments (control and H2O2), MRT (model dependent) and 
T63 (model independent) were not significantly different from one another. 
 The overall dynamics of the PO2mv response (MRT and T63) were ~80-90% slower with 
H2O2 compared to control. As a result of the similar overall PO2mv amplitude regardless of the 
one- or two-component model fit (ΔTotalPO2mv) in the two experimental treatments, the 
contracting steady-state PO2mv (PO2mv(SS)) was ~30% greater with H2O2 compared with control. 
The acute effects of H2O2 treatment on PO2mv kinetics were reflected in the overall muscle 
microvascular oxygenation (PO2AREA) throughout the on-transition, as H2O2 increased PO2AREA 
by ~33% relative to control (Fig. 4.3, bottom panel). 
 
Muscle blood flow ( mQ ) 
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 MAP values were not different during mQ  measurements when comparing distinct 
conditions (control: 95 ± 3; H2O2: 96 ± 5 mmHg; P>0.05). H2O2 treatment augmented 
significantly resting and contracting mQ when compared to control (Fig. 4.4). However, no 
further increases in mQ  during the rest-contraction transient occurred with H2O2 (P>0.05). 
 
Muscle O2 utilization ( 2OV
 ) 
 Relative to the control condition, H2O2 treatment augmented significantly resting and 
contracting 2OV
  (Fig. 4.5). A similar magnitude of increase in muscle 2OV  (Δ 2OV ) from rest to 
contractions was observed for both conditions (control: 5.7 ± 0.8; H2O2: 6.0 ± 1.1 mL/min/100g; 
P>0.05). 
 
Muscle force production 
 As illustrated in Fig. 4.6, muscle force production was not significantly different 
throughout the contraction period between control and H2O2. Thus, as a consequence of the 
relatively greater contracting steady-state 2OV
  (Fig. 4.5), H2O2 treatment decreased the 
force/ 2OV
  relationship by ~40% when compared to control (Fig. 4.6, inset). 
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 Discussion 
 
This study evaluated the effects of acute H2O2 exposure on skeletal muscle function at 
rest and during contractions in healthy young rats. Consistent with our hypothesis, redox 
modulation via H2O2 treatment elevated PO2mv at rest and during contractions while slowing its 
kinetics, an effect that reflected significant disproportionate increases in muscle 2OQ
  and 2OV . 
However, contrary to our expectation, H2O2 treatment did not increase muscle force production. 
These results demonstrate that, although enhancing the driving force for blood-myocyte O2 
transfer, increased H2O2 reduces acutely the economy of contractions (i.e., decreased force/ 2OV
  
relationship). 
 
H2O2 modulates skeletal muscle function 
Acute exposure of isolated skeletal muscle arterioles to H2O2 modulates myogenic tone in 
a concentration- and time-dependent manner, such that exogenous 100 µM H2O2 produces 
biphasic changes composed of a brief constriction followed by a substantial vasodilation that 
reaches steady-state within ~3 min (16). Enhanced arteriolar tone appears to be primarily 
mediated by the release of endothelium- and smooth muscle-derived constrictor prostaglandins 
(prostaglandin H2 and thromboxane A2), whereas decreased arteriolar tone is caused mainly by 
the activation of both eNOS and K
+
 channels (including Ca
2+
-activated and ATP-sensitive K
+
 
channels) in the smooth muscle (16). These effects are consistent with the stimulatory actions of 
H2O2 on eNOS activity (12, 27, 63, 64) and the identification of H2O2 as an EDHF (34, 51). 
Although the relative importance of each vasodilatory pathway in skeletal muscle is currently 
unknown, augmented accumulation of endogenous H2O2 contributes substantially to functional 
vasodilation given that catalase treatment blunts the increase in skeletal muscle arteriolar 
diameter during contractions (32). Elevated mQ  at rest and during contractions under H2O2 
treatment in the present investigation (Fig. 4.4) corroborates and extends significantly the 
aforementioned studies by demonstrating that acute increases in H2O2 modulate skeletal muscle 
blood flow and microvascular oxygenation in situ. 
 Although not every PO2mv profile exhibited a transient fall consistent with the biphasic 
arteriolar diameter response reported by Csekő et al. (16), exogenous H2O2 increased resting 
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spinotrapezius PO2mv in all instances within ~30 s (Fig. 4.2). In addition to differences in 
experimental design (see below), this behavior could also be explained by the fact that PO2mv is 
directly proportional to the 2OQ
 / 2OV  ratio (10) while arteriolar diameter measurements only 
provide an index of 2OQ
 . This is particularly important considering that altered H2O2 levels also 
impact mitochondrial function (and thus muscle 2OV
 ). Tonkonogi et al. (57) documented a 
significant impairment in the coupling between respiration and phosphorylation (as assessed by a 
decrease in the respiratory control index; i.e., the ratio of state 3 to state 4 mitochondrial 
respiration) and an approximately 19% reduction in phosphorylation efficiency (decreased P/O 
ratio; i.e., the relationship between ATP resynthesis and O2 consumption) in isolated skeletal 
muscle mitochondria exposed to 100 µM H2O2. These effects are partially mediated by an 
increase in proton leakage through the adenine nucleotide translocase protein (an antiporter that 
exchanges ADP for ATP across the inner mitochondrial membrane) (57). Teleologically, a 
greater proton leakage promoted by elevated H2O2 levels could serve as a compensatory 
mechanism, since the consequent reduction in mitochondrial proton gradient and membrane 
potential would attenuate ROS production and thus limit potential oxidative damage (54, 60). It 
is important to note that participation of other ROS such as the hydroxyl radical (which can be 
generated via the interaction between ferrous iron and H2O2; i.e., the Fenton reaction) is unlikely 
to occur given that the iron chelator deferoxamine does not attenuate the effects of H2O2 
treatment on mitochondrial respiration (52). Our data are consistent with those of Tonkonogi et 
al. (57) and reveal that H2O2 treatment markedly increased resting and contracting steady-state 
2OV
  in healthy rat skeletal muscle (Fig. 4.5). The observation of similar Δ 2OV  from rest to 
contractions for control and H2O2 treatment supports the notion that H2O2 impacted 
mitochondrial control rather than the contractile apparatus. Although increased NO 
bioavailability (induced by the stimulatory actions of H2O2 on eNOS activity; refs. 12, 27, 63, 
64) could act to inhibit mitochondrial respiration (13), that the net effect of acute H2O2 treatment 
is increased basal and contracting 2OV
  (Fig. 4.5) suggests that the actions of H2O2 on oxidative 
phosphorylation overcame those of NO. 
The temporal profile of PO2mv during metabolic transitions reflects the dynamic 
2OQ
 / 2OV  ratio within the microvascular space (10, 25). Collectively, our data indicate that the 
elevated PO2mv response from rest to submaximal contractions under H2O2 treatment (Table 4.1 
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and Fig. 4.3) resulted from disproportionate increases in 2OQ
  and 2OV  (Figs. 4.4 and 4.5). 
These effects can be summarized by analysis of the PO2AREA, which was ~33% greater with 
H2O2 compared to control (Fig. 4.3, bottom panel). However, the greater potential for blood-
myocyte O2 flux under H2O2 treatment occurs at the expense of an elevated O2 cost of 
contraction as evidenced by an increased muscle 2OV
  (Fig. 4.5) concurrent with unchanged 
force production (i.e., ~40% decrease in the force/ 2OV
  relationship; Fig. 4.6). Such reduced 
muscle economy could compromise sustained contractile activity by exacerbating perturbations 
of the intramyocyte physicochemical milieu (e.g., accentuated depletion of phosphocreatine and 
glycogen stores; ref. 1). 
 Skeletal muscle contractile function is influenced by ROS bioavailability and its effects 
on myocyte redox state (20, 46, 48). The conceptual model developed by Reid et al. (4, 48, 49) 
describes the relationship between muscle redox balance and submaximal force production as a 
bell-shaped response profile (Fig. 4.7). This model predicts that a certain level of ROS 
accumulation is necessary to cause a rightward shift along the response curve from the relatively 
reduced redox state of unfatigued skeletal muscle towards the optimal redox state where force 
production is maximized. Exogenous H2O2 evokes concentration- and time-dependent effects on 
skeletal muscle force production (4, 49). Specifically, brief exposure of isolated muscle fibers to 
H2O2 (100-300 µM for 3 min) increases submaximal force production without alterations in 
myoplasmic Ca
2+
 concentration, supporting the notion of a redox modulation of Ca
2+
 sensitivity 
(4, see also refs. 37, 55). Elevated myofiber Ca
2+
 sensitivity with increased H2O2 could alleviate 
fatigue momentarily until prolonged exposure and/or further ROS accumulation decrease Ca
2+
 
sensitivity and force production (4, 55). The mechanisms involved in the modulation of Ca
2+
 
sensitivity by H2O2 appear to depend on its interaction with myoglobin and glutathione (a non-
enzymatic thiol antioxidant in muscle fibers) in a concentration- and time-dependent manner 
(37). 
Contrary to our hypothesis, we observed that H2O2 treatment did not change force 
production compared to control (Fig. 4.6). The reasons for this divergence are unclear, but may 
relate to: (i) the utilization of distinct experimental protocols (including the influence of 
temperature on ROS bioavailability and myofiber Ca
2+
 sensitivity since studies conducted in 
isolated preparations are commonly performed at subphysiological temperatures to promote 
stability; refs. 7, 36); (ii) muscle fiber type; as the mixed fiber type spinotrapezius muscle (18) 
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could retain the resistance to ROS-induced increases in Ca
2+
 sensitivity of the contractile 
apparatus characteristic of predominantly slow-twitch fibers (37); (iii) a rightward shift along the 
bell-shaped response profile that places the muscle past the optimal redox state and results in 
similar force production compared to control (see Fig. 4.7); (iv) compartmentalized ROS 
scavenging that suppresses the potential effects of H2O2 treatment on force production (see 
below); (v) the opposing effects of endogenous NO on contractile function (e.g., reduced 
myofiber Ca
2+
 sensitivity; refs. 5, 55). 
 
Experimental considerations 
 Modulation of physiological responses to altered H2O2 bioavailability appears to be 
specific to the tissue under consideration. Within the cardiovascular system, H2O2 is capable of 
evoking vasoconstriction, vasodilation or a biphasic response depending on the vascular bed (i.e., 
location and branch order), vascular tone (i.e., basal contractile state, method utilized to induce 
tone in isolated preparations), resting membrane potential, age and/or disease status (8, 16, 22, 
32, 34, 35, 43, 51, 53, 58, 63, 64). Distinct localization, activity and/or expression of antioxidant 
systems as well as differences in individual peroxidase enzyme kinetics result in redox 
compartmentalization (i.e., specific tissue and cellular concentrations of ROS) (40). These and 
potentially other factors interact to regulate local redox state and dictate spatial and temporal 
heterogeneity in the physiological responses to transient changes in H2O2 levels. Caution is 
therefore required when extrapolating findings from different sites within the cardiovascular 
system (e.g., skeletal muscle, coronary, cerebral and mesenteric circulations). Furthermore, 
marked skeletal muscle fiber type differences in ROS generation and scavenging (3, 46) suggest 
that a given stimulus (e.g., contractions, redox modulation via oxidant or antioxidant treatment) 
might produce dissimilar outcomes. In this regard, it is pertinent that the rat spinotrapezius 
muscle exhibits a mixed fiber type composition and oxidative capacity that resemble closely the 
human quadriceps (18, 30), thus representing a useful surrogate of human skeletal muscle. The 
spinotrapezius preparation also allows superfusion as a method to deliver specific compounds to 
the muscle, which is expected to modify only local redox state and avoid the potential for 
systemic influences (e.g., alterations in MAP). 
 It is unlikely that our acute H2O2 treatment (100 µM) produced loss of vascular and/or 
skeletal muscle function. Accordingly, H2O2 washout in preliminary studies from our laboratory 
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(Hirai DM, Copp SW, Schwagerl PJ, Musch TI, Poole DC; unpublished data) revealed that 
PO2mv returned to pre-treatment values (i.e., PO2mv(Pre)) in approximately 20 min. Data from 
these preliminary studies also indicated no impairment in force production during an additional 
third contraction bout performed in identical fashion to the control condition. These findings are 
consistent with previous studies utilizing similar H2O2 concentrations. Specifically, Csekő et al. 
(16) reported that H2O2 washout restored baseline arteriolar diameter and Andrade et al. (4) 
documented reversible effects of H2O2 on muscle force production after incubation with the 
reductant dithiothreitol. 
 Although increased H2O2 is capable of stimulating metabosensitive afferents in skeletal 
muscle (17, 62), that no changes in MAP were observed for H2O2 treatment when compared to 
control argues against that possibility. It is feasible that the present H2O2 concentration and/or 
relatively small muscle mass of the spinotrapezius limited the triggering of these events. 
 
Limitations 
Given the nature of our experimental protocol, muscle tissue analysis for ROS was not 
feasible due to the two required contraction bouts (control and H2O2). Blood samples were not 
taken for ROS measurements since, as noted above, the superfusion method utilized herein was 
expected to impact only local redox state. Nevertheless, the exogenous application of H2O2 via 
superfusion of the rat spinotrapezius muscle is similar to that employed by others and has been 
demonstrated, although indirectly, to impact effectively intracellular H2O2 levels (32). 
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 Conclusions 
 
The current study demonstrates for the first time that acute H2O2 treatment promoted 
disproportionate increases in skeletal muscle 2OQ
  and 2OV  both at rest and during submaximal 
contractions in situ. These alterations modified significantly microvascular O2 delivery-
utilization balance such that PO2mv was elevated at rest and throughout contractions (along with 
~85% slower overall kinetics) compared to the control condition. However, the greater potential 
for blood-myocyte O2 flux under H2O2 treatment occurred concurrently with reduced economy 
of contractions as revealed by the significant decrease in the force/ 2OV
  relationship. These novel 
findings indicate that, while potentially improving vascular function, transient increases in H2O2 
have detrimental effects on skeletal muscle function (i.e., augmented O2 cost of force production) 
that may contribute to exercise intolerance in conditions associated with oxidative stress. 
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Table 4.1 Muscle PO2mv at rest and following the onset of contractions under control and 
H2O2 treatments 
 Control H2O2 
PO2mv(Pre), mmHg 31.6 ± 1.6 33.5 ± 2.3 
PO2mv(Post), mmHg 31.9 ± 1.6 39.0 ± 2.6* 
Δ1PO2mv, mmHg 11.7 ± 0.7 12.6 ± 1.4 
Δ2PO2mv, mmHg 2.9 ± 0.2 - 
ΔTotalPO2mv, mmHg 12.3 ± 0.9 12.6 ± 1.4 
PO2mv(SS), mmHg 20.8 ± 1.4 27.0 ± 2.6* 
TD1, s 5.5 ± 1.2 0.2 ± 0.2* 
TD2, s 54.5 ± 15.2 - 
τ1, s 18.7 ± 3.2 43.3 ± 6.6* 
τ2, s 19.0 ± 6.4 - 
MRT, s 24.2 ± 3.0 43.5 ± 6.6* 
T63, s 24.2 ± 3.1 46.5 ± 7.4* 
PO2mv(Pre), pre-treatment resting PO2mv; PO2mv(Post), post-treatment resting PO2mv; Δ1PO2mv, 
amplitude of the first component; Δ2PO2mv, amplitude of the second component; ΔTotalPO2mv, 
overall amplitude regardless of one- or two-component model fit; PO2mv(SS), contracting steady-
state PO2mv; TD1, time delay for the first component; TD2, time delay for the second 
component; τ1, time constant for the first component; τ2, time constant for the second 
component; MRT, mean response time; T63, time to reach 63% of the overall amplitude as 
determined independent of modeling procedures. The one-component exponential model was 
used to analyze the PO2mv kinetics in the majority of instances (16 out of 20) in the control 
condition and in all cases for H2O2. * Significantly different from control. 
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Figure 4.1 Experimental protocol 
 
 
Figure 4.1 Schematic representation of the protocol utilized in the current study (diagram not to 
scale). Control, Krebs-Henseleit solution; H2O2; hydrogen peroxide. See text for details. 
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Figure 4.2 Muscle PO2mv during control and H2O2 superfusion conditions 
 
 
Figure 4.2 Typical relative changes in spinotrapezius muscle microvascular PO2 (PO2mv) during 
K-H (control; dotted line) and H2O2 (100 µM; continuous lines) superfusion and incubation 
periods (approximately 0-90 and 90-250 s, respectively). Note that, although not all PO2mv 
profiles exhibited an initial transient fall following H2O2 superfusion consistent with the brief 
arteriolar constriction response to exogenous H2O2 (100 µM) in isolated vessels reported by 
Csekő et al. (16), we observed that H2O2 treatment increased basal PO2mv in all instances. 
Steady-state PO2mv values were reached within ~3 min following H2O2 superfusion. Time zero 
denotes start of the H2O2 superfusion period. See text for discussion. 
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Figure 4.3 Muscle PO2mv following the onset of contractions under control and H2O2 
conditions 
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Figure 4.3 Mean spinotrapezius muscle microvascular PO2 (PO2mv) following the onset of 
contractions under control and H2O2 treatments. Top and middle panels exhibit absolute and 
relative PO2mv, respectively. SE bars omitted from middle panel for clarity. Time zero depicts 
the onset of muscle contractions. Note that exogenous H2O2 affected markedly PO2mv kinetics 
during submaximal contractions (see Table 4.1 for details). The bottom panel shows the mean 
values for the area under the microvascular PO2 curve (PO2AREA) following the onset of 
contractions under control and H2O2 treatments. PO2AREA was determined through integration of 
the area under the PO2mv curve over the 3 min stimulation period for each condition. * 
Significantly different from control. 
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Figure 4.4 Muscle blood flow at rest and during contractions under control and H2O2 
conditions 
 
 
Figure 4.4 Mean spinotrapezius muscle blood flow at rest and during contractions under control 
and H2O2 treatments. * Significantly different from control within the same condition (i.e., rest 
or contractions). † Significantly different from rest. 
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Figure 4.5 Muscle 2OV

 at rest and during contractions under control and H2O2 conditions 
 
 
Figure 4.5 Mean spinotrapezius muscle O2 utilization ( 2OV
 ) at rest and during contractions 
under control and H2O2 treatments. * Significantly different from control within the same 
condition (i.e., rest or contractions). † Significantly different from rest. 
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Figure 4.6 Muscle force production under control and H2O2 conditions 
 
 
Figure 4.6 Mean spinotrapezius muscle force production under control and H2O2 treatments. 
Note that muscle force production was not significantly different throughout the contraction 
period between control and H2O2. The inset shows the force/ 2OV
  relationship for both 
treatments. As a result of the greater muscle 2OV
  induced by H2O2 (Fig. 4.4), a reduction of 
~40% in the force/ 2OV
  relationship was observed. * Significantly different from control. 
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Figure 4.7 Redox regulation of submaximal muscle force production 
 
 
Figure 4.7 Hypothetical model illustrating the redox regulation of submaximal muscle force 
production as proposed originally by Reid et al. (4, 48, 49). The model predicts that deviations 
from optimal redox state are associated with reduced muscle force production. For any given 
condition, the putative location on the biphasic response profile is depicted as a potential range 
(i.e., circles demarcated by dotted lines) and not as a definite point since it is not possible to 
precisely and directly determine redox state (46, 48). Unfatigued muscle redox state at rest is 
located slightly to the left of the optimal for contractile function, whereas muscle contractions 
under control conditions enhance ROS accumulation thus shifting the muscle to the right towards 
greater force production. Acute oxidant treatment with H2O2 is expected to further push muscle 
redox state to the right compared to control contractions. Similar force production under H2O2 
treatment relative to control in the current study may have resulted, in part, from a rightward 
shift along the bell-shaped response profile placing muscle redox state beyond the optimal point 
as depicted in the figure. As such, the correspondence between force production in the control 
and H2O2 conditions would be coincidental. See text for discussion. 
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108 
 
 Summary 
 
Exercise training induces multiple adaptations within skeletal muscle that may improve 
local O2 delivery-utilization matching (i.e., PO2mv). We tested the hypothesis that increased 
nitric oxide (NO) function is intrinsic to improved muscle PO2mv kinetics from rest to 
contractions after exercise training. Healthy young Sprague-Dawley rats were assigned to 
sedentary (n=18) or progressive treadmill exercise training (n=10; 5 d/wk, 6-8 wks, final 
workload of 60 min/d at 35 m/min, -14% grade) groups. PO2mv was measured via 
phosphorescence quenching in the spinotrapezius muscle at rest and during 1 Hz twitch 
contractions under control (Krebs-Henseleit solution), sodium nitroprusside (SNP, NO donor; 
300 µM) and N
G
-nitro-L-arginine methyl ester (L-NAME, non-specific NOS blockade; 1.5 mM) 
superfusion conditions. Exercise trained rats had greater peak oxygen uptake ( peakOV 2
 ) than 
their sedentary counterparts (81 ± 1 vs. 72 ± 2 ml/kg/min, respectively; p<0.05). Exercise trained 
rats had significantly slower PO2mv fall throughout contractions (τ1; time constant for the first 
component) during control (sedentary: 8.1 ± 0.6; trained: 15.2 ± 2.8 s). Compared to control, 
SNP slowed τ1 to a greater extent in sedentary rats (sedentary: 38.7 ± 5.6; trained: 26.8 ± 4.1 s; 
p<0.05) whereas L-NAME abolished the differences in τ1 between sedentary and trained rats 
(sedentary: 12.0 ± 1.7; trained: 11.2 ± 1.4 s; p<0.05). Our results indicate that endurance exercise 
training leads to greater muscle microvascular oxygenation across the metabolic transient 
following the onset of contractions (i.e., slower PO2mv kinetics) partly via increased NO-
mediated function which likely constitutes an important mechanism for training-induced 
metabolic adaptations. 
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 Introduction 
 
Endurance exercise training induces multiple structural and functional adaptations that 
enhance the capacities for skeletal muscle O2 delivery and utilization ( 2OQ
  and 2OV , 
respectively; refs. 37, 58, 71). At any given submaximal contractile activity, this cluster of 
adaptations reduces the level of metabolic perturbations (e.g., changes in ADP, PCr and Cr 
concentrations) required to drive 2OV
  and improves the coupling between energy utilization and 
muscle mitochondrial ATP production (70). These properties reduce the rate of glycolysis and 
reliance on finite energy sources and increase exercise tolerance (37). 
Microcirculatory adaptations to training are particularly important considering that the 
greatest resistance to O2 flux into skeletal muscle fibers resides primarily in the short distance 
between the red blood cell and the adjacent subsarcolemmal space (23, 29). As dictated by Fick’s 
law of diffusion, the O2 pressure within the microvasculature (i.e., muscle PO2mv) constitutes the 
exclusive driving force for blood-myocyte O2 transfer. The time course of skeletal muscle 
PO2mv during transitions in metabolic demand is determined by the dynamic matching between 
2OQ
  and 2OV  (i.e., 22 / OVOQ 
  ratio) (8). Therefore, because alterations in muscle PO2mv have a 
direct impact on oxidative metabolism and contractile performance (36, 68), increased PO2mv 
during contractions likely contributes to the beneficial effects of exercise training on muscle 
function. 
Substantial evidence indicates that increased nitric oxide (NO) function is a key factor 
improving skeletal muscle hemodynamic and metabolic control following exercise training (28, 
53). Moreover, previous reports from our laboratory indicate that alterations in NO levels impact 
profoundly muscle PO2mv during transitions in metabolic demand in health and disease (24, 25, 
31) and suggest that increased NO-mediated function could underlie, at least in part, enhanced 
muscle microvascular oxygenation in the trained state. 
 The purpose of the present study was to determine the effects of endurance 
exercise training on muscle PO2mv and whether augmented NO-mediated function contributes 
mechanistically to potential increases in PO2mv from rest to contractions in rat skeletal muscle in 
situ after training. Based on the potential enhancement of NO-mediated function following 
endurance exercise training (28, 53), the hypotheses were tested that 1) exercise training would 
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elevate muscle PO2mv and slow PO2mv kinetics (i.e., resulting in higher PO2mv across the on-
contraction transient); 2) increased NO levels (via the NO donor sodium nitroprusside; SNP) 
would elevate PO2mv and slow PO2mv kinetics to a greater extent in sedentary compared to 
trained rats; and 3) reduced NO levels (non-specific NO synthase blockade with N
G
-nitro-L-
arginine methyl ester; L-NAME) would lower PO2mv and speed PO2mv kinetics to a greater 
extent in trained compared to sedentary rats during the transition from rest to contractions. 
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 Methods 
 
Animal selection and care 
A total of 28 male Sprague-Dawley rats (4-5 months old; Charles Rivers Laboratories, 
Boston, MA, USA) were used to investigate the effects of exercise training on, and the NO 
contribution to, skeletal muscle microvascular oxygenation. Additional rats were used in 
supplementary experiments to 1) evaluate the reproducibility and demonstrate the lack of an 
ordering effect of the protocol (n=7); and 2) assess potential cyanide-induced impairment of 
skeletal muscle function with the current SNP superfusion protocol (n=9). All experimental 
procedures followed guidelines established by the National Institutes of Health and were 
approved by the Institutional Animal Care and Use Committee of Kansas State University. Rats 
were maintained on a 12:12-h light-dark cycle with food and water provided ad libitum. Before 
initiation of the experimental protocol, rats were familiarized with downhill running on a 
custom-built motor-driven treadmill over the course of a 1 wk period (5-10 min/day at a speed of 
20 m/min and -14% grade). After the familiarization phase, rats were assigned randomly to either 
sedentary (n=18) or endurance exercise trained (n=10) groups. Sedentary control rats were 
confined to cage activities whereas trained rats ran 5 days/wk for 6-8 wks on the declined 
treadmill (-14% grade). All rats underwent the same training program, in which treadmill 
running duration and speed were increased progressively from 10 min at 25 m/min to 60 min at 
35 m/min. This final workload was kept for at least 3-4 wks. Previous work from our laboratory 
has demonstrated that downhill treadmill running recruits the rat spinotrapezius muscle (41, 57) 
and constitutes an effective model for exercise training programs (30). 
 
peakOV 2
  measurements 
Upon completion of the training program, peak oxygen uptake ( peakOV 2
 ) was measured 
in sedentary and trained rats during a downhill (-14% grade) running test performed in a 
metabolic chamber placed on the treadmill. As described in detail previously (16, 30), the speed 
was set initially to 25 m/min for 2-3 min and then increased progressively in a ramp-like fashion 
by ~5-10 m/min until the rat was unable to keep pace with the treadmill belt or no further 
elevations in 2OV
  were observed despite continued increases in treadmill speed. At this point of 
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the test peakOV 2
  was measured and recorded. Alterations in gait (e.g., lowering of the 
hindlimbs, dropping of the tail and elevation of the snout) normally occurred immediately prior 
to termination of the test. Six of the 28 rats tested had to repeat their maximal tests on a separate 
day (i.e., ≥24 hours of recovery) due to failure to achieve the predetermined criteria. Gas 
measurements were performed in real time via an inline O2 analyzer (model S-3A/I; AEI 
Technologies; Pittsburgh, PA, USA). The analyzer was calibrated before and after each maximal 
exercise test with precision-mixed gases that spanned the expected range of gas concentrations 
based on previous studies. We have reported recently highly reproducible peakOV 2
  
measurements using the aforementioned techniques and protocol (16). 
 
Surgical preparation 
On the day of data collection, rats were anesthetized initially with 5% isoflurane-O2 
mixture and subsequently maintained on 2-3% isoflurane-O2 (Butler Animal Health Supply, 
Dublin, OH, USA). The left carotid and caudal (tail) arteries were cannulated (PE-10 connected 
to PE-50; Intra-Medic Tubing, Clay Adams Brand, Sparks, MD, USA) for continuous 
monitoring of mean arterial pressure (MAP; Digi-Med BPA Model 200, Louisville, KY, USA) 
and infusion of the phosphorescent probe palladium meso-tetra (4-carboxyphenyl) porphyrin 
dendrimer (R2; 15 mg/kg; Oxygen Enterprises, Philadelphia, PA, USA). Blood from the tail 
catheter was sampled at the end of each experimental protocol for determination of arterial blood 
gases, pH and systemic hematocrit (Nova Stat Profile M, Waltham, MA, USA). Anesthetized 
rats were placed on a heating pad to maintain core temperature, measured via rectal probe, at 
~37-38°C. 
Following catheter placement procedures, isoflurane inhalation was discontinued 
progressively and rats were kept under anesthesia with intra-arterial pentobarbital sodium 
throughout the experiment. The level of anesthesia was monitored frequently via the toe-pinch 
and blink reflexes and supplemented as necessary. Overlying skin and fascia from the mid-dorsal 
region of the rat were reflected carefully to expose the right spinotrapezius muscle. The 
spinotrapezius was moistened constantly during the surgical preparation via superfusion of 
Krebs-Henseleit (K-H) bicarbonate-buffered solution (4.7 mM KCl, 2.0 mM CaCl2, 2.4 mM 
MgSO4, 131 mM NaCl and 22 mM NaHCO3; pH = 7.4; equilibrated with 5% CO2 and 95% N2 
at ~38°C). Surrounding tissue was covered with Saran wrap (Dow Brands, Indianapolis, IN, 
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USA). Stainless steel electrodes were sutured to the rostral (cathode) and caudal (anode) regions 
of the spinotrapezius for electrically induced contractions. Previous reports from our laboratory 
demonstrate that these surgical procedures do not impact the microvascular integrity and 
responsiveness of the spinotrapezius muscle (3). 
 
Experimental protocol 
 Three separate contraction bouts were performed under control (5 ml K-H), SNP (NO 
donor; 5 ml of a 300 µM solution) and L-NAME (non-isoform specific NO synthase inhibitor; 5 
ml of a 1.5 mM solution) superfusion conditions. Drugs were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) and concentrations were chosen based on previous studies in our laboratory 
(24, 25, 31). All solutions were maintained at ~38°C. The dose of SNP was titrated to elicit 
consistent alterations in PO2mv without compromising systemic hemodynamics (i.e., a decrease 
in MAP below 70 mmHg at any time; refs. 10, 25). Preliminary experiments indicate that 
significantly greater hypotensive responses and increases in resting PO2mv are evoked by 
progressively higher SNP doses (up to 1200 µM; unpublished data). In order to prevent SNP 
photodecomposition and potential cyanide release (11, 13), SNP solutions were protected from 
light sources by covering containers and syringes with aluminum foil and, as a mandate for 
PO2mv measurements using phosphorescence quenching, performing our experiments in a dark 
room. While superfusion order was randomized between control and SNP conditions, L-NAME 
was always the last treatment because of its relatively long half-life. The spinotrapezius was 
superfused with each solution (average flow rate of ~1.5 ml/min) for a total time of 3 min, 
followed by a 2-3 min incubation period to allow resting muscle PO2mv to stabilize. 
Subsequently, electrical stimulation (1 Hz, 6-7 V, 2 ms pulse duration) of the muscle was evoked 
via a Grass stimulator (model s48, Quincy, MA, USA) for 3 min. The muscle was then allowed 
to recover for ~25 min before the next condition was initiated (stimulation parameters were held 
constant). During the recovery period following the SNP trial, the muscle was superfused at an 
average flow rate of ~1.5 ml/min with K-H to wash out SNP. At the end of each experiment, rats 
were euthanized with intra-arterial pentobarbital sodium overdose (~50 mg/kg). 
 
Supplementary experiments 
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The spinotrapezius preparation exhibits reproducible PO2mv parameters during 
transitions in metabolic demand evoked by 1 Hz twitch contractions when a minimum of 20 min 
of recovery is allowed between contraction bouts (31, 34). A >30 min period between 
consecutive contractions (i.e., 3 min off-transition, ~25 min recovery, 3 min superfusion, 2-3 min 
incubation) was employed herein to prevent any priming and drug ordering effects that could 
confound the experimental interpretation of the PO2mv responses to muscle contractions (9, 25). 
Accordingly, supplementary time control experiments (n=7) revealed reproducible PO2mv 
profiles from three contraction bouts separated by ~30 min (within-animal coefficient of 
variation: 13 ± 2% for baseline, steady-state and all primary component kinetics parameters) 
with no ordering effect (p>0.05 for baseline, steady-state and all kinetics parameters). 
Considerable controversy exists surrounding potential cyanide generation from SNP (11, 
13, 27) despite widespread usage of this NO donor in both clinical and research arenas (human 
and animal models). A major source of this controversy may lie within the methods utilized for 
assaying blood cyanide concentrations and the importance of photodecomposition in generating 
cyanide from SNP (during both SNP infusion and cyanide measurement; refs. 11, 13). As 
described above, in the current study SNP solutions were protected from light sources by 
covering containers and syringes with aluminum foil and performing experiments in a dark 
room. Nonetheless, supplementary experiments were conducted to examine potential cyanide-
induced impairment of skeletal muscle function with the current SNP superfusion protocol. 
Three contraction bouts were conducted in the following superfusion order: control 1 (K-H), 
SNP (300 µM), control 2 (K-H). Recovery time and washout procedures were identical to those 
described above. Spinotrapezius muscle PO2mv was measured at rest and throughout 
contractions (n=9). Spinotrapezius muscle blood flow ( mQ ) and oxygen utilization ( 2OV ) were 
determined at rest and during the contraction steady-state via radiolabeled microspheres and 
direct Fick calculation (as described in detail previously, ref. 34), respectively (n=4). In each 
condition, the stimulated right and non-stimulated left spinotrapezius muscles represented the 
contracting and resting mQ  and 2OV  measurements, respectively. 
During mQ  measurements, the tail artery catheter was connected to a 1 ml syringe and 
blood withdrawal was initiated at a constant rate of 0.25 ml/min via a Harvard pump (model 
907). Differentially radiolabelled microspheres (
46
Sc and 
85
Sr, 15 µm diameter; Perkin Elmer 
Life and Analytical Sciences) were injected in random order into the aortic arch via the carotid 
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artery catheter during the contracting steady-state (i.e., ~3 min after onset of muscle 
contractions). Upon completion of the experiment, the right and left spinotrapezius muscles and 
kidneys were dissected, removed and weighted immediately after euthanasia. The thorax was 
opened and placement of the artery catheter into the aortic arch was confirmed. Tissue 
radioactivity was determined on a gamma scintillation counter (Packard Auto Gamma 
Spectrometer, Cobra model 5003) and mQ  was determined by the reference method (39) and 
expressed as ml/min/100 g of tissue. Adequate mixing of the microspheres was verified for each 
injection by demonstrating a <15% difference in mQ  between the right and left kidneys. 
 Spinotrapezius muscle 2OV
  was estimated from PO2mv and mQ  measurements as 
described in detail previously (34). Briefly, arterial O2 concentration (CaO2) was calculated from 
arterial blood samples whereas venous O2 concentration (CvO2) was calculated from the resting 
or contracting steady-state PO2mv using the rat O2 dissociation curve (Hill coefficient of 2.6), the 
measured hemoglobin (Hb) concentration, a P50 of 38 mmHg, and an O2 carrying capacity of 
1.34 ml O2/g Hb (1). Resting and contracting steady-state spinotrapezius mQ  values were then 
used to calculate 2OV
  using the Fick equation (i.e., )( 222 CvOCaOmQOV 
 ). As illustrated in 
Fig. 5.1, results from these experiments suggest that mitochondrial and vascular control were not 
impaired following the SNP condition. 
 
Muscle PO2mv measurement 
 PO2mv was measured by phosphorescence quenching using a Frequency Domain 
Phosphorometer (PMOD 5000; Oxygen Enterprises, Philadelphia, PA, USA). The principles of 
the phosphorescence quenching method have been described in detail previously (8). Briefly, this 
method applies the Stern-Volmer relationship (63), which describes quantitatively the O2 
dependence of the phosphorescent probe (R2) via the following equation: 
 
)/(]1)/[(2   QkmvPO  
 
where Qk  is the quenching constant and   and   are the phosphorescence lifetimes in the 
absence of O2 and the ambient O2 concentration, respectively. The phosphor R2 (   = 601 µs 
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and Qk  = 409 mmHg
-1.s
-1
 at pH = 7.4 and temperature ~38°C) (50) was infused ~15 min before 
initiation of muscle contractions. The R2 probe binds to albumin and is distributed uniformly in 
the plasma, therefore providing a signal corresponding to the volume-weighted O2 pressure in the 
microvascular compartment (mainly the PO2 within the capillaries, which volumetrically 
represents the major intramuscular space; ref. 59). The negative charge of the R2 probe also 
facilitates its restriction to the muscle intravascular space (60). The common end of the 
bifurcated light guide was positioned 2-4 mm superficial to the dorsal surface of the exposed 
spinotrapezius muscle. The phosphorometer modulates sinusoidal excitation frequencies between 
100 Hz and 20 kHz and allows phosphorescence lifetime measurements from 10 µs to ~2.5 ms. 
The excitation light (524 nm) was focused on a randomly selected area of ~2 mm diameter of 
exposed muscle and has a penetration depth of ~500 µm. PO2mv was recorded at 2 s intervals 
throughout the duration of the experimental protocol (i.e., superfusion, incubation, electrical 
stimulation and recovery periods). 
 Movement of the light guide and/or animal was avoided so as to monitor the same 
sampling site during experiments. However, alteration of the PO2mv measurement plane (e.g., 
deep sighs, accidental splash of the light guide during superfusion) during muscle contractions 
precluded kinetic curve fitting in some instances. Thus, PO2mv results from the present study are 
presented from animals under the following conditions: sedentary control (n=18); sedentary SNP 
(n=14); sedentary L-NAME (n=14); trained control (n=10); trained SNP (n=9); trained L-NAME 
(n=10). 
 
PO2mv kinetics analysis 
 The kinetics of PO2mv were described by nonlinear regression analysis using the 
Marquardt-Levenberg algorithm (SigmaPlot 11.2; Systat software, San Jose, CA, USA) for the 
onset of contractions. Transient PO2mv responses were fit with either a one- or two-component 
model (7, 8): 
 
One-component: 
)1( /)(2)(2)(2
TDt
BLt emvPOmvPOmvPO
  
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Two-component: 
)1()1( 2
/)2(
22
1/)1(
21)(2)(2
 TDtTDt
BLt emvPOemvPOmvPOmvPO
   
 
where PO2mv(t) is the PO2mv at a given time t, PO2mv(BL) corresponds to the pre-contracting 
resting PO2mv, Δ1 and Δ2 are the amplitudes for the first and second components, respectively, 
TD1 and TD2 are the independent time delays for each component, and τ1 and τ2 are the time 
constants (i.e., time to achieve 63% of the response) for each component. Goodness of fit was 
determined using three criteria: 1) the coefficient of determination; 2) the sum of squared 
residuals; and 3) visual inspection. 
The mean response time (MRT; ref. 51) was used to describe the overall dynamics of the 
PO2mv response: 
 
TDMRT  
 
where TD and τ are defined above. The MRT analysis was limited to the first component of the 
PO2mv response given that inclusion of an emergent second component underestimates the 
actual speed of PO2mv fall following the onset of contractions (33, 34). 
 
Citrate synthase activity measurement 
 The activity of the mitochondrial enzyme citrate synthase (a marker of oxidative 
capacity) from the spinotrapezius and select individual hindlimb muscles or muscle parts (soleus, 
red gastrocnemius, mixed gastrocnemius and plantaris) was measured in duplicate from muscle 
homogenates by a modification of the method described by Srere (66). Upon termination of the 
experimental protocol and euthanasia, the muscles were removed, dissected free of connective 
tissue and weighed. Citrate synthase activity was measured spectrophotometrically (Spectramax 
M5 microplate, Molecular Devices, Sunnyvale, CA, USA) in 300 µL aliquots at 30°C. 
 
Statistical analyses 
 Data comparison was performed using unpaired Student’s t-test, Mann-Whitney rank-
sum test or two-way repeated measures ANOVA where appropriate. F-statistics were calculated 
using Type III (adjusted) sums of squares due to the unbalanced nature of the data. Student-
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Newman-Keuls post hoc test was utilized to determine where the differences were located. A 
one-tail test was performed when a priori directional hypotheses were tested (24, 25). The level 
of significance was set at p<0.05. Results are presented as mean ± SE. 
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 Results 
 
Body mass and spinotrapezius muscle mass were not different between sedentary (462 ± 
12 and 0.43 ± 0.1 g; respectively) and exercise trained (480 ± 9 and 0.44 ± 0.1 g; respectively) 
rats after the training program was completed (p>0.05 for both). There were no differences in 
arterial O2 saturation (sedentary: 91.0 ± 1.7; trained: 93.6 ± 1.7%), PO2 (sedentary: 91.9 ± 3.3; 
trained: 94.2 ± 3.6 mmHg), PCO2 (sedentary: 37.3 ± 1.7; trained: 35.5 ± 0.5 mmHg), pH 
(sedentary: 7.40 ± 0.01; trained: 7.42 ± 0.01) and systemic hematocrit (sedentary: 34.9 ± 0.8; 
trained: 37.2 ± 0.7%) when comparing sedentary and trained rats (p>0.05 for all). 
Exercise trained rats evidenced higher peakOV 2
  (sedentary: 72 ± 2; trained: 81 ± 1 
ml/kg/min; p<0.05) than sedentary rats. Citrate synthase activity was higher in the soleus 
(sedentary: 17.5 ± 0.5; trained: 20.9 ± 1.5 µmol/g/min) and red gastrocnemius (sedentary: 24.2 ± 
0.5; trained: 30.2 ± 1.1 µmol/g/min) muscles from trained rats (p<0.05 for both). There was a 
tendency for greater citrate synthase activity in the mixed gastrocnemius (sedentary: 15.9 ± 1.1; 
trained: 18.7 ± 1.9; µmol/g/min; p=0.064) and plantaris (sedentary: 13.5 ± 0.8; trained: 16.3 ± 
1.8 µmol/g/min; p=0.058) muscles from trained rats. Unexpectedly, citrate synthase activity from 
the spinotrapezius was not different between sedentary and trained rats (13.4 ± 0.7 and 12.9 ± 0.7 
µmol/g/min, respectively; p>0.05). 
 
Effects of exercise training on muscle PO2mv 
 MAP was not different in sedentary compared to exercise trained rats either before or 
after K-H superfusion (Table 5.1; p>0.05). Although PO2mv values at rest (PO2mv(BL)) and 
during the contracting steady-state (PO2mv(SS)) were not different between groups (p>0.05 for 
both), exercise training induced significant differences in the time course of PO2mv at the onset 
of contractions under the control condition (Figs. 5.2 and 5.3, Table 5.2). Specifically, the speed 
of PO2mv fall during contractions (as assessed by the time constant for the first component and 
relative rate of PO2mv fall; τ1 and Δ1PO2mv/τ1, respectively) was markedly slowed in trained 
compared to sedentary rats (Fig. 5.3). No significant differences in the time delay for the first 
component (TD1, p>0.05) were observed whereas the mean response time (MRT) tended to be 
longer in trained rats (p = 0.13; Table 5.2). 
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Effects of altered NO on muscle PO2mv in sedentary and exercise trained rats 
 SNP superfusion decreased MAP to a greater degree in trained compared to sedentary 
rats (Table 5.1; p<0.05). Relative to the control condition, SNP increased PO2mv(BL) in both 
sedentary and trained rats (Table 5.2; p<0.05). Although SNP increased the overall amplitude of 
PO2mv fall during contractions (ΔTotalPO2mv) only in trained rats, there were no differences in 
PO2mv(SS) between sedentary and trained rats (Table 5.2). Both groups exhibited greater 
PO2mv(SS) with SNP when compared to the control condition (p<0.05; Table 5.2). As illustrated 
in Fig. 5.2, SNP had strikingly distinct effects on the PO2mv time course following the onset of 
contractions in sedentary and trained rats. Albeit no differences between groups were found in 
TD1 with SNP (p>0.05), τ1 and MRT were increased to a greater extent in sedentary compared to 
trained rats (p<0.05; Table 5.2 and Fig. 5.3). Analysis of Δ1PO2mv/τ1 indicates that SNP slowed 
the relative rate of PO2mv fall during contractions in sedentary but not trained rats (Fig. 5.3; 
p<0.05). Additionally, there was a tendency for Δ1PO2mv/τ1 to be slower in sedentary compared 
to trained rats during the SNP condition (Fig. 5.3; p = 0.12). 
 L-NAME superfusion did not change MAP in either sedentary or exercise trained rats 
(Table 5.1; p>0.05). Although L-NAME did not significantly modify PO2mv(BL) and 
ΔTotalPO2mv, both sedentary and trained rats had lower PO2mv(SS) compared to their control 
conditions (Table 5.2; p<0.05). The effects of NO synthase inhibition with L-NAME were such 
that the spinotrapezius muscle PO2mv profile from rest to contractions in trained rats was similar 
to that of sedentary rats (Figs. 5.2 and 5.3, Table 5.2). Relative to the control condition, L-
NAME significantly speeded TD1 in both sedentary and trained rats (Table 5.2). Notably, L-
NAME abolished the differences in τ1, Δ1PO2mv/τ1 and MRT between sedentary and trained rats 
evident during the control condition (p>0.05 for all; Table 5.2 and Fig. 5.3). Moreover, L-NAME 
speeded Δ1PO2mv/τ1 in trained rats to similar values found in sedentary rats (Fig. 5.3). 
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 Discussion 
 
The present study demonstrates that endurance exercise training improves significantly 
the microvascular oxygenation profile (i.e., slowed PO2mv kinetics and therefore enhanced 
PO2mv) across the metabolic transient following the onset of contractions in the spinotrapezius 
muscle of healthy young rats. Compared to the control condition, increased NO with SNP slowed 
the PO2mv fall throughout contractions (τ1) to a greater extent in sedentary rats whereas 
decreased NO with L-NAME abolished the differences in τ1 between sedentary and trained rats. 
These results suggest that the enhanced driving force for blood-myocyte O2 flux during 
contractions with exercise training is mediated, at least in part, via increased NO-mediated 
function. 
 
Exercise training and muscle microvascular oxygenation 
 As stated above, muscle PO2mv kinetics is dictated by the dynamic 22 / OVOQ
  matching 
within the microvascular space (8). Slowed PO2mv kinetics in trained rats (Figs. 5.2 and 5.3, 
Table 5.2) therefore suggest that the rate of adjustment in 2OQ
  during contractions was 
relatively faster than that of 2OV
  compared to sedentary rats (5, 21, 26), such that fractional O2 
extraction was reduced up until the steady-state is achieved. The unexpected lack of change in 
citrate synthase activity found herein with training further supports this notion (see discussion 
below). Enhanced 2OQ
  across the rest-contractions transient with training is important to 
support potential augmented mitochondrial function (37, 70) and/or attenuate regional 
22 / OVOQ
  mismatch (45), both of which might be linked mechanistically to faster muscle 2OV  
kinetics and improved exercise tolerance. With respect to the capacity to extract O2 it is 
important to note that there is an interdependence between the diffusive and conductive O2 
transport components (62): 
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where DO2 is the effective muscle O2 diffusing capacity, β corresponds to the slope of the O2 
dissociation curve in the physiologically relevant range and mQ is muscle blood flow. Although 
DO2 represents a lumped parameter that includes the impediments to blood-myocyte O2 transfer 
and is determined by a complex interaction between structural and functional factors, it appears 
that DO2 is dictated largely by capillary hematocrit and the volume density of red blood cell 
flowing capillaries (23, 29, 58, 62). As β is unlikely to be affected appreciably by exercise 
training, alterations in O2 extraction will depend on the DO2/ mQ  ratio (62). The significance of 
the abovementioned relationship is that it provides information regarding alterations in diffusive 
and conductive components of O2 transport. Given that exercise training is known to improve 
both DO2 (4, 54, 62) and mQ  kinetics (65), it can be surmised that trained rats had a relatively 
greater increase in microvascular mQ  than in DO2 (i.e., lower DO2/ mQ  ratio, which dictates 
reduced fractional O2 extraction) across the rest-contractions transient. This analysis suggests 
that adaptations in conductive (mainly red blood cell flux; fRBC) rather than diffusive capillary 
mechanisms with exercise training are of relatively greater importance in setting enhanced 
muscle microvascular oxygenation during metabolic transients as measured herein (Fig. 5.2 and 
Table 5.2). Importantly, the resultant slowed PO2mv kinetics and reduced fractional O2 
extraction act to increase the pressure head for O2 diffusion at a time when 2OV
  is rising at its 
fastest rate and would therefore be expected to improve muscle O2 supply and oxidative function 
(5, 8, 36, 44, 68). 
 
Effects of altered NO on PO2mv kinetics 
 NO and its derivatives modulate multiple physiological processes including muscle 
hemodynamic and metabolic control (12, 67). More specifically, NO contributes to the increase 
in muscle 2OQ
  during contractions mainly via endothelium-dependent vasodilation (28, 32, 35, 
53) and to the inertia of oxidative metabolism (i.e., finite 2OV
  kinetics) via inhibition of 
mitochondrial respiration (40, 43). Accordingly, alterations in NO levels modulate the dynamic 
22 / OVOQ
  matching during metabolic transitions in health and disease (24, 25, 31). The lack of 
change in citrate synthase activity with training in the current investigation support that SNP and 
L-NAME treatments had similar effects on 2OV
  dynamics of sedentary and trained rats. 
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Consequently, this implies that differences in the PO2mv profiles between sedentary and trained 
rats with SNP and L-NAME resulted primarily from alterations in 2OQ
 . 
 The main effects of altered NO with either SNP or L-NAME were seen during the 
contraction transient (Figs. 5.2 and 5.3, Table 5.2). Specifically, SNP slowed τ1 to a greater 
extent in sedentary rats whereas L-NAME abolished the differences in τ1 between sedentary and 
trained rats that were evident in the control condition (Fig. 5.3). These results suggest that 
exercise training increases the contribution of NO to the dynamic 22 / OVOQ
  matching and 
enhances the capacity for O2 flux across metabolic transients in healthy skeletal muscle. 
 
Primary mechanisms for slowed PO2mv kinetics with training 
 From the above it becomes apparent that the principal mechanisms improving 
microvascular oxygenation with exercise training likely involve enhanced NO-mediated 
regulation of fRBC. Potential candidates include 1) enhanced endothelial-mediated vasodilation 
(28, 53); and/or 2) enhanced attenuation of sympathetic vasoconstriction (i.e., functional 
sympatholysis; ref. 69); and/or 3) training-induced alterations in mQ  distribution (2, 35) that 
could attenuate spatial heterogeneities in contracting muscle microvascular oxygenation (45). 
Although it must be acknowledged that aging and disease states also present impairments 
in muscle DO2, it is interesting to note that these conditions are characterized by reduced NO-
mediated function (20, 32, 56) and demonstrate opposite effects on capillary hemodynamics (i.e., 
impaired fRBC; refs. 17, 61) and 22 / OVOQ
  matching (i.e., faster PO2mv kinetics; refs. 6, 21) 
during contractions when compared to healthy young individuals. In this context, endurance 
exercise training has profound clinical implications especially for aged and diseased populations 
as it constitutes a non-pharmacological therapeutic intervention capable of mitigating 
microcirculatory deficits. 
  Vascular control mechanisms (35, 48) and vascular adaptations to exercise training (2, 
52) are known to vary according to muscle fiber type composition and oxidative capacity. 
Consequently, differences might exist in the relative contribution of NO to alterations in gas 
exchange properties of the microcirculation with training in muscles comprised of distinct fiber 
types. In this regard, it is noteworthy that the spinotrapezius possesses a mixed fiber type 
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composition and oxidative capacity that resembles the human quadriceps (19, 49), therefore 
representing a useful analogue of human locomotor muscle. 
 
Experimental considerations 
 Downhill treadmill running was used herein as a model of endurance exercise training 
given that this protocol recruits the rat spinotrapezius muscle (41, 57) and may promote training 
adaptations that include increased peakOV 2
 , muscle citrate synthase activity and resistance to 
fatigue (30). Accordingly, exercise training protocols that do not recruit the spinotrapezius (e.g., 
inclined treadmill running) do not induce changes in PO2mv kinetics in healthy young rats (55, 
cf. refs. 46, 47). It is important to note that, in the current investigation, trained rats had ~12% 
greater peakOV 2
  as well as distinct MAP and PO2mv responses following SNP and L-NAME 
superfusion (Tables 5.1 and 5.2, Figs. 5.2 and 5.3) when compared to sedentary rats, thus 
providing compelling evidence of a training effect. Furthermore, the markedly slowed PO2mv 
kinetics (Figs. 5.2 and 5.3, Table 5.2) is consistent with expected adaptations to training. While 
the lack of change in citrate synthase activity of the spinotrapezius muscle in trained rats is 
surprising, it suggests that adaptations in vascular control (i.e., improved fRBC as discussed 
above) likely facilitated the enhanced microvascular oxygenation seen herein during contractions 
in the trained state. In this sense, potential structural and/or functional vascular adaptations (i.e., 
↑ flow capacity; the potential for conductive delivery of blood to and from exchange vessels) that 
occurred independent of alterations in mitochondrial oxidative capacity in trained rats could 
enhance the dynamic 22 / OVOQ
  matching and improve the ability of the microcirculation to 
support skeletal muscle metabolism. 
Eccentric exercise such as downhill running promotes muscle damage that impairs 
capillary hemodynamics and microvascular O2 transfer during subsequent contractile activity 
(42, see also ref. 18). Interestingly, evidence from both human and animal studies indicates that 
muscle damage from a single bout of eccentric exercise is considerably reduced following 
repeated bouts as performed herein and any damage from the first bout(s) would be expected to 
have ameliorated during the ~2 month training period (14, 64). Although unlikely, any potential 
deleterious effects of eccentric exercise on muscle function would therefore only underestimate 
the improvements in PO2mv kinetics with training. 
125 
 
 Reduced driving pressure with SNP (Table 5.1) could constrain blood flow dynamics and 
influence PO2mv kinetics during metabolic transitions. However, previous studies from our 
laboratory (10) indicate that this effect is negligible when MAP is above ~70 mmHg as herein. 
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 Conclusions 
 
Resolution of muscle PO2mv kinetics and their mechanistic bases in the exercise trained 
state are essential to understand how muscle microcirculatory plasticity evokes improvements in 
contractile performance. The current novel findings in healthy skeletal muscle suggest that 
endurance exercise training enhances microvascular oxygenation during contractions (i.e., 
slowed PO2mv kinetics) partly via increased NO-mediated function. As mentioned above, 
enhanced PO2mv during metabolic transitions facilitates blood-myocyte O2 flux to support 
oxidative phosphorylation and consequently reduces the rate of anaerobic glycolysis and reliance 
on finite energy sources, all of which likely contribute to improved muscle contractile 
performance following exercise training (36, 37, 58, 68, 70). Important clinical implications arise 
from our results considering that aged and patient (e.g., chronic heart failure; CHF) populations 
are characterized by reduced NO signaling (20, 32, 56), impaired microvascular oxygenation (6, 
21) and poor exercise capacity (15, 38). It is noteworthy that CHF patients, for instance, retain 
considerable plasticity within their skeletal muscle O2 transport system (both convective and 
diffusive components) in response to exercise training programs (22). Taken together, these 
observations suggest that exercise training is a powerful non-pharmacological strategy to 
improve NO-mediated function, thereby likely ameliorating muscle microvascular oxygenation 
deficits and exercise intolerance in aging and disease states.
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Table 5.1 Mean arterial pressure (MAP; expressed in mmHg) pre- and post-superfusion of Krebs-Henseleit (Control), SNP 
and L-NAME in sedentary and exercise trained rats 
 Control  SNP  L-NAME 
 Pre Post  Pre Post  Pre Post 
Sedentary 123 ± 4 124 ± 4  125 ± 5 111 ± 4*  128 ± 4 132 ± 5 
Trained 132 ± 3 133 ± 4  134 ± 5 95 ± 6*†  134 ± 4 137 ± 4 
Values are mean ± SE. Results are presented from animals under the following conditions: sedentary control (n=18); sedentary SNP 
(n=14); sedentary L-NAME (n=14); trained control (n=10); trained SNP (n=9); trained L-NAME (n=10). Significantly different from: 
* all other conditions within group; † sedentary post-SNP superfusion. 
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Table 5.2 Muscle PO2mv kinetics following the onset of contractions under control, SNP and L-NAME conditions in sedentary 
and exercise trained rats 
 Control  SNP  L-NAME 
 Sedentary Trained  Sedentary Trained  Sedentary Trained 
PO2mv(BL), mmHg 29.2 ± 1.3 27.8 ± 1.2  38.7 ± 2.3* 42.9 ± 3.5*  25.5 ± 1.7† 26.4 ± 1.5† 
Δ1PO2mv, mmHg 11.4 ± 1.2 10.6 ± 0.8  9.3 ± 2.3 15.6 ± 3.3‡  13.0 ± 1.0 13.0 ± 1.2 
Δ2PO2mv, mmHg 2.3 ± 0.3 2.5 ± 0.3  - -  2.3 ± 0.4 2.8 ± 1.3 
ΔTotalPO2mv, mmHg 9.8 ± 1.2 8.6 ± 0.8  9.3 ± 1.5 15.6 ± 3.3*‡  11.2 ± 0.9 12.1 ± 1.1 
PO2mv(SS), mmHg 19.4 ± 1.0 19.2 ± 1.5  29.4 ± 1.5* 27.3 ± 1.4*  14.3 ± 0.8*† 14.2 ± 0.9*† 
TD1, s 10.2 ± 0.7 10.3 ± 1.6  8.3 ± 1.6 11.8 ± 3.6  6.2 ± 0.5* 6.5 ± 0.9*† 
TD2, s 55.1 ± 9.5 53.4 ± 12.4  - -  55.0 ± 6.8 41.3 ± 7.2 
τ2, s 39.5 ± 7.8 32.3 ± 10.1  - -  55.5 ± 8.9 51.9 ± 18.9 
MRT, s 18.3 ± 0.9 25.5 ± 3.3
#
  47.0 ± 5.8* 38.6 ± 5.2*‡  18.1 ± 1.7† 17.7 ± 1.6† 
Values are mean ± SE. PO2mv(BL), resting PO2mv; Δ1PO2mv, amplitude of the first component; Δ2PO2mv, amplitude of the second 
component; ΔTotalPO2mv, overall amplitude regardless of one- or two-component model fit; PO2mv(SS), contracting steady-state 
PO2mv; TD1, time delay for the first component; TD2, time delay for the second component; τ2, time constant for the second 
component, MRT, mean response time. The time constant for the first component (τ1) and relative rate of PO2mv fall (Δ1PO2mv/τ1) are 
shown in Fig. 5.3. The one-component exponential model was used to analyze the PO2mv kinetics in the following conditions: 
sedentary control (6/18), sedentary SNP (14/14), sedentary L-NAME (3/14), trained control (2/10), trained SNP (9/9), trained L-
NAME (7/10). Significantly different from: * control within group; † SNP within group; ‡ sedentary within superfusion condition. # 
p=0.13 vs. sedentary control. 
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Figure 5.1 Investigation of potential cyanide-induced impairment of skeletal muscle 
function 
 
 
Figure 5.1 Results from experiments performed to examine potential cyanide-induced 
impairment of skeletal muscle function with the current SNP superfusion protocol. Three 
contraction bouts were conducted in the following superfusion order: control 1 (K-H), SNP (300 
µM), control 2 (K-H). Spinotrapezius muscle PO2mv was measured at rest and throughout 
contractions (n=9). Spinotrapezius muscle blood flow ( mQ ) and oxygen utilization ( 2OV ) were 
determined at rest and during the contraction steady-state via radiolabeled microspheres and 
direct Fick calculation, respectively (n=4). Top panels: Spinotrapezius mQ  and 2OV  at rest and 
during the contraction steady-state during the first and third bouts (i.e., control 1 and 2, 
respectively). Bottom panel: Spinotrapezius PO2mv at rest and following the onset of 
contractions under all three conditions (control 1, SNP and control 2). Time zero denotes the 
130 
 
onset of contractions. That resting and contracting spinotrapezius muscle 2OV
  did not differ 
between the first and third bouts (i.e., control 1 vs. control 2; p>0.05) suggests preserved 
mitochondrial function post-SNP condition. The possibility of prolonged and/or irreversible 
vasodilation following the SNP condition is not supported based on similar resting and 
contraction steady-state mQ  between the first and third bouts (i.e., control 1 vs. control 2; 
p>0.05). Similar PO2mv profiles during the first and third bouts (i.e., control 1 vs. control 2; 
p>0.05 for all kinetics parameters) are also consistent with the notion that mitochondrial and 
vascular control were not impaired following the SNP condition (i.e., second bout). n.s., not 
significantly different. 
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Figure 5.2 Muscle PO2mv from sedentary and exercise trained rats under control, SNP and 
L-NAME conditions 
 
 
Figure 5.2 Spinotrapezius muscle PO2mv response from representative sedentary and exercise 
trained rats under control, SNP and L-NAME conditions. Time zero denotes the onset of 
contractions. Note that exercise training slowed the PO2mv fall during contractions (τ1, time 
constant for the first component) under control. SNP slowed τ1 to a greater extent in sedentary 
rats whereas L-NAME abolished the differences in τ1 between sedentary and trained rats (see 
text for details). 
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Figure 5.3 Muscle PO2mv kinetics in sedentary and exercise trained rats under control, 
SNP and L-NAME conditions 
 
 
Figure 5.3 Spinotrapezius muscle PO2mv kinetics (top panel: τ1, time constant for the first 
component; bottom panel: Δ1PO2mv/τ1; relative rate of PO2mv fall) in sedentary and exercise 
trained rats under control, SNP and L-NAME conditions. Significantly different from: * control 
within group; † SNP within group; ‡ sedentary within superfusion condition. # p=0.12 vs. 
sedentary SNP. 
133 
 
 References 
 
1. Altman PL, and Dittmer DS. Biology Data Book. Bethesda, MD: FASEB, 1974. 
2. Armstrong RB, and Laughlin MH. Exercise blood flow patterns within and among rat 
muscles after training. Am J Physiol 246: H59-68, 1984. 
3. Bailey JK, Kindig CA, Behnke BJ, Musch TI, Schmid-Schoenbein GW, and Poole 
DC. Spinotrapezius muscle microcirculatory function: effects of surgical exteriorization. Am J 
Physiol Heart Circ Physiol 279: H3131-3137, 2000. 
4. Bebout DE, Hogan MC, Hempleman SC, and Wagner PD. Effects of training and 
immobilization on 2OV
  and DO2 in dog gastrocnemius muscle in situ. J Appl Physiol 74: 1697-
1703, 1993. 
5. Behnke BJ, Barstow TJ, Kindig CA, McDonough P, Musch TI, and Poole DC. 
Dynamics of oxygen uptake following exercise onset in rat skeletal muscle. Respir Physiol 
Neurobiol 133: 229-239, 2002. 
6. Behnke BJ, Delp MD, Dougherty PJ, Musch TI, and Poole DC. Effects of aging on 
microvascular oxygen pressures in rat skeletal muscle. Respir Physiol Neurobiol 146: 259-268, 
2005. 
7. Behnke BJ, Kindig CA, McDonough P, Poole DC, and Sexton WL. Dynamics of 
microvascular oxygen pressure during rest-contraction transition in skeletal muscle of diabetic 
rats. Am J Physiol Heart Circ Physiol 283: H926-932, 2002. 
8. Behnke BJ, Kindig CA, Musch TI, Koga S, and Poole DC. Dynamics of 
microvascular oxygen pressure across the rest-exercise transition in rat skeletal muscle. Respir 
Physiol 126: 53-63, 2001. 
9. Behnke BJ, Kindig CA, Musch TI, Sexton WL, and Poole DC. Effects of prior 
contractions on muscle microvascular oxygen pressure at onset of subsequent contractions. J 
Physiol 539: 927-934, 2002. 
10. Behnke BJ, Padilla DJ, Ferreira LF, Delp MD, Musch TI, and Poole DC. Effects of 
arterial hypotension on microvascular oxygen exchange in contracting skeletal muscle. J Appl 
Physiol 100: 1019-1026, 2006. 
134 
 
11. Bisset WI, Butler AR, Glidewell C, and Reglinski J. Sodium nitroprusside and cyanide 
release: reasons for re-appraisal. Br J Anaesth 53: 1015-1018, 1981. 
12. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411: 
351-369, 1999. 
13. Butler AR, Glidewell C, McGinnis J, and Bisset WI. Further investigations regarding 
the toxicity of sodium nitroprusside. Clin Chem 33: 490-492, 1987. 
14. Byrnes WC, Clarkson PM, White JS, Hsieh SS, Frykman PN, and Maughan RJ. 
Delayed onset muscle soreness following repeated bouts of downhill running. J Appl Physiol 59: 
710-715, 1985. 
15. Clark AL, Poole-Wilson PA, and Coats AJ. Exercise limitation in chronic heart failure: 
central role of the periphery. J Am Coll Cardiol 28: 1092-1102, 1996. 
16. Copp SW, Davis RT, Poole DC, and Musch TI. Reproducibility of endurance capacity 
and peakOV 2
  in male Sprague-Dawley rats. J Appl Physiol 106: 1072-1078, 2009. 
17. Copp SW, Ferreira LF, Herspring KF, Musch TI, and Poole DC. The effects of aging 
on capillary hemodynamics in contracting rat spinotrapezius muscle. Microvasc Res 77: 113-
119, 2009. 
18. Davies RC, Eston RG, Poole DC, Rowlands AV, DiMenna F, Wilkerson DP, Twist 
C, and Jones AM. Effect of eccentric exercise-induced muscle damage on the dynamics of 
muscle oxygenation and pulmonary oxygen uptake. J Appl Physiol 105: 1413-1421, 2008. 
19. Delp MD, and Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and 
citrate synthase activity of rat muscle. J Appl Physiol 80: 261-270, 1996. 
20. Didion SP, and Mayhan WG. Effect of chronic myocardial infarction on in vivo 
reactivity of skeletal muscle arterioles. Am J Physiol 272: H2403-2408, 1997. 
21. Diederich ER, Behnke BJ, McDonough P, Kindig CA, Barstow TJ, Poole DC, and 
Musch TI. Dynamics of microvascular oxygen partial pressure in contracting skeletal muscle of 
rats with chronic heart failure. Cardiovasc Res 56: 479-486, 2002. 
22. Esposito F, Reese V, Shabetai R, Wagner PD, and Richardson RS. Isolated 
quadriceps training increases maximal exercise capacity in chronic heart failure: the role of 
skeletal muscle convective and diffusive oxygen transport. J Am Coll Cardiol 58: 1353-1362, 
2011. 
135 
 
23. Federspiel WJ, and Popel AS. A theoretical analysis of the effect of the particulate 
nature of blood on oxygen release in capillaries. Microvasc Res 32: 164-189, 1986. 
24. Ferreira LF, Hageman KS, Hahn SA, Williams J, Padilla DJ, Poole DC, and Musch 
TI. Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability. 
Acta Physiol (Oxf) 188: 3-13, 2006. 
25. Ferreira LF, Padilla DJ, Williams J, Hageman KS, Musch TI, and Poole DC. Effects 
of altered nitric oxide availability on rat muscle microvascular oxygenation during contractions. 
Acta Physiol (Oxf) 186: 223-232, 2006. 
26. Ferreira LF, Poole DC, and Barstow TJ. Muscle blood flow-O2 uptake interaction and 
their relation to on-exercise dynamics of O2 exchange. Respir Physiol Neurobiol 147: 91-103, 
2005. 
27. Friederich JA, and Butterworth JFt. Sodium nitroprusside: twenty years and counting. 
Anesth Analg 81: 152-162, 1995. 
28. Green DJ, Maiorana A, O'Driscoll G, and Taylor R. Effect of exercise training on 
endothelium-derived nitric oxide function in humans. J Physiol 561: 1-25, 2004. 
29. Groebe K, and Thews G. Calculated intra- and extracellular PO2 gradients in heavily 
working red muscle. Am J Physiol 259: H84-92, 1990. 
30. Hahn SA, Ferreira LF, Williams JB, Jansson KP, Behnke BJ, Musch TI, and Poole 
DC. Downhill treadmill running trains the rat spinotrapezius muscle. J Appl Physiol 102: 412-
416, 2007. 
31. Hirai DM, Copp SW, Ferreira LF, Musch TI, and Poole DC. Nitric oxide 
bioavailability modulates the dynamics of microvascular oxygen exchange during recovery from 
contractions. Acta Physiol (Oxf) 200: 159-169, 2010. 
32. Hirai DM, Copp SW, Hageman KS, Poole DC, and Musch TI. Aging alters the 
contribution of nitric oxide to regional muscle hemodynamic control at rest and during exercise 
in rats. J Appl Physiol 111: 989-998, 2011. 
33. Hirai DM, Copp SW, Herspring KF, Ferreira LF, Poole DC, and Musch TI. Aging 
impacts microvascular oxygen pressures during recovery from contractions in rat skeletal 
muscle. Respir Physiol Neurobiol 169: 315-322, 2009. 
136 
 
34. Hirai DM, Copp SW, Schwagerl PJ, Musch TI, and Poole DC. Acute effects of 
hydrogen peroxide on skeletal muscle microvascular oxygenation from rest to contractions. J 
Appl Physiol 110: 1290-1298, 2011. 
35. Hirai T, Visneski MD, Kearns KJ, Zelis R, and Musch TI. Effects of NO synthase 
inhibition on the muscular blood flow response to treadmill exercise in rats. J Appl Physiol 77: 
1288-1293, 1994. 
36. Hogan MC, Arthur PG, Bebout DE, Hochachka PW, and Wagner PD. Role of O2 in 
regulating tissue respiration in dog muscle working in situ. J Appl Physiol 73: 728-736, 1992. 
37. Holloszy JO, and Coyle EF. Adaptations of skeletal muscle to endurance exercise and 
their metabolic consequences. J Appl Physiol 56: 831-838, 1984. 
38. Inbar O, Oren A, Scheinowitz M, Rotstein A, Dlin R, and Casaburi R. Normal 
cardiopulmonary responses during incremental exercise in 20- to 70-yr-old men. Med Sci Sports 
Exerc 26: 538-546, 1994. 
39. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, and Frohlich ED. Reference sample 
microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol 239: H443-
H449, 1980. 
40. Jones AM, Wilkerson DP, Koppo K, Wilmshurst S, and Campbell IT. Inhibition of 
nitric oxide synthase by L-NAME speeds phase II pulmonary 2OV
  kinetics in the transition to 
moderate-intensity exercise in man. J Physiol 552: 265-272, 2003. 
41. Kano Y, Padilla D, Hageman KS, Poole DC, and Musch TI. Downhill running: a 
model of exercise hyperemia in the rat spinotrapezius muscle. J Appl Physiol 97: 1138-1142, 
2004. 
42. Kano Y, Padilla DJ, Behnke BJ, Hageman KS, Musch TI, and Poole DC. Effects of 
eccentric exercise on microcirculation and microvascular oxygen pressures in rat spinotrapezius 
muscle. J Appl Physiol 99: 1516-1522, 2005. 
43. Kindig CA, McDonough P, Erickson HH, and Poole DC. Nitric oxide synthase 
inhibition speeds oxygen uptake kinetics in horses during moderate domain running. Respir 
Physiol Neurobiol 132: 169-178, 2002. 
44. Kindig CA, Richardson TE, and Poole DC. Skeletal muscle capillary hemodynamics 
from rest to contractions: implications for oxygen transfer. J Appl Physiol 92: 2513-2520, 2002. 
137 
 
45. Koga S, Poole DC, Ferreira LF, Whipp BJ, Kondo N, Saitoh T, Ohmae E, and 
Barstow TJ. Spatial heterogeneity of quadriceps muscle deoxygenation kinetics during cycle 
exercise. J Appl Physiol 103: 2049-2056, 2007. 
46. Lash JM. Exercise training enhances adrenergic constriction and dilation in the rat 
spinotrapezius muscle. J Appl Physiol 85: 168-174, 1998. 
47. Lash JM, and Bohlen HG. Functional adaptations of rat skeletal muscle arterioles to 
aerobic exercise training. J Appl Physiol 72: 2052-2062, 1992. 
48. Laughlin MH, and Armstrong RB. Adrenoreceptor effects on rat muscle blood flow 
during treadmill exercise. J Appl Physiol 62: 1465-1472, 1987. 
49. Leek BT, Mudaliar SR, Henry R, Mathieu-Costello O, and Richardson RS. Effect of 
acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am J 
Physiol Regul Integr Comp Physiol 280: R441-447, 2001. 
50. Lo LW, Vinogradov SA, Koch CJ, and Wilson DF. A new, water soluble, phosphor 
for oxygen measurements in vivo. Adv Exp Med Biol 428: 651-656, 1997. 
51. Macdonald M, Pedersen PK, and Hughson RL. Acceleration of 2OV
  kinetics in heavy 
submaximal exercise by hyperoxia and prior high-intensity exercise. J Appl Physiol 83: 1318-
1325, 1997. 
52. McAllister RM, Jasperse JL, and Laughlin MH. Nonuniform effects of endurance 
exercise training on vasodilation in rat skeletal muscle. J Appl Physiol 98: 753-761, 2005. 
53. McAllister RM, Newcomer SC, and Laughlin MH. Vascular nitric oxide: effects of 
exercise training in animals. Appl Physiol Nutr Metab 33: 173-178, 2008. 
54. McAllister RM, and Terjung RL. Training-induced muscle adaptations: increased 
performance and oxygen consumption. J Appl Physiol 70: 1569-1574, 1991. 
55. McCullough DJ, Davis RT, 3rd, Dominguez JM, 2nd, Stabley JN, Bruells CS, and 
Behnke BJ. Effects of aging and exercise training on spinotrapezius muscle microvascular PO2 
dynamics and vasomotor control. J Appl Physiol 110: 695-704, 2011. 
56. Muller-Delp JM, Spier SA, Ramsey MW, and Delp MD. Aging impairs endothelium-
dependent vasodilation in rat skeletal muscle arterioles. Am J Physiol Heart Circ Physiol 283: 
H1662-1672, 2002. 
57. Musch TI, and Poole DC. Blood flow response to treadmill running in the rat 
spinotrapezius muscle. Am J Physiol 271: H2730-2734, 1996. 
138 
 
58. Poole DC. Influence of exercise training on skeletal muscle oxygen delivery and 
utilization. In: The Lung: Scientific Foundations, edited by Crystal RG, West JB, Weibel ER, 
and Barnes PJ. New York: Raven Press, 1997, p. 1957-1967. 
59. Poole DC, Behnke BJ, McDonough P, McAllister RM, and Wilson DF. Measurement 
of muscle microvascular oxygen pressures: compartmentalization of phosphorescent probe. 
Microcirculation 11: 317-326, 2004. 
60. Poole DC, Wagner PD, and Wilson DF. Diaphragm microvascular plasma PO2 
measured in vivo. J Appl Physiol 79: 2050-2057, 1995. 
61. Richardson TE, Kindig CA, Musch TI, and Poole DC. Effects of chronic heart failure 
on skeletal muscle capillary hemodynamics at rest and during contractions. J Appl Physiol 95: 
1055-1062, 2003. 
62. Roca J, Agusti AG, Alonso A, Poole DC, Viegas C, Barbera JA, Rodriguez-Roisin R, 
Ferrer A, and Wagner PD. Effects of training on muscle O2 transport at max2OV
 . J Appl 
Physiol 73: 1067-1076, 1992. 
63. Rumsey WL, Vanderkooi JM, and Wilson DF. Imaging of phosphorescence: a novel 
method for measuring oxygen distribution in perfused tissue. Science 241: 1649-1651, 1988. 
64. Schwane JA, and Armstrong RB. Effect of training on skeletal muscle injury from 
downhill running in rats. J Appl Physiol 55: 969-975, 1983. 
65. Shoemaker JK, Phillips SM, Green HJ, and Hughson RL. Faster femoral artery blood 
velocity kinetics at the onset of exercise following short-term training. Cardiovasc Res 31: 278-
286, 1996. 
66. Srere PA. Citrate synthase. Methods in Enzymology 13: 3-11, 1969. 
67. Stamler JS, and Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 
81: 209-237, 2001. 
68. Stary CM, and Hogan MC. Effect of varied extracellular PO2 on muscle performance in 
Xenopus single skeletal muscle fibers. J Appl Physiol 86: 1812-1816, 1999. 
69. Thomas GD, and Victor RG. Nitric oxide mediates contraction-induced attenuation of 
sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506 ( Pt 3): 817-826, 1998. 
70. Tonkonogi M, and Sahlin K. Physical exercise and mitochondrial function in human 
skeletal muscle. Exerc Sport Sci Rev 30: 129-137, 2002. 
139 
 
71. Whyte JJ, and Laughlin MH. The effects of acute and chronic exercise on the 
vasculature. Acta Physiol (Oxf) 199: 441-450, 2010. 
140 
 
Chapter 6 - Conclusions 
Integrating the investigations described in this dissertation, we conclude that alterations 
in NO bioavailability have a substantial impact on skeletal muscle 22 / OVOQ
  matching 
following both the onset and cessation of contractions. Disparate muscle PO2mv kinetics in 
health and disease can be ascribed partially to alterations in NO levels. Specifically, our data 
demonstrate that increased NO levels (via the NO donor sodium nitroprusside; SNP) elevates 
muscle PO2mv whereas reduced NO levels (non-specific NOS inhibition with N
G
-nitro-L-
arginine methyl ester; L-NAME) diminishes muscle PO2mv across the metabolic transient 
following the onset and cessation of contractions in the spinotrapezius muscle of healthy young 
rats. Moreover, utilization of selective nNOS inhibition (S-methyl-L-thiocitrulline; SMTC) 
reveals that alterations in nNOS-mediated regulation of contracting skeletal muscle 
microvascular function with advanced age likely contribute to reduced exercise capacity in this 
population. Pronounced oxidative stress is implicated in these pathological responses observed in 
aged and diseased states. Accordingly, transient elevations in the oxidant H2O2 to levels found in 
the early stages of senescence and cardiovascular diseases have detrimental effects on skeletal 
muscle function (i.e., augmented oxygen cost of force production). On the other hand, endurance 
exercise training improves muscle microvascular oxygenation (i.e., greater PO2mv across the 
metabolic transient and slower PO2mv kinetics) partly via enhanced NO-mediated function in 
healthy young individuals. Important clinical applications arise from these investigations when 
considering that exercise training could ameliorate NO-mediated function, muscle microvascular 
oxygenation deficits and exercise intolerance in aged and diseased populations. 
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